ORPHENGESIC FORTE 50 MG / 770 MG / 60 MG Oral Tablet

ASA 770 MG / Caffeine 60 MG / Orphenadrine Citrate 50 MG Oral Tablet [Orphengesic]

Orphengesic (ASA 770 MG / caffeine 60 MG / orphenadrine citrate 50 MG) Oral Tablet

aspirin 770 MG / caffeine 60 MG / orphenadrine citrate 50 MG Oral Tablet [Orphengesic]


Valstar 200 MG per 5 ML Irrigation Solution

VALSTAR 200 MG per 5 ML (40 MG/ML) Irrigation Solution

valrubicin 40 MG/ML Irrigation Solution [Valstar]


Xopenex 1.25 MG (as levalbuterol hydrochloride 1.44 MG) per 3 ML Inhalation Solution

Xopenex 1.25 MG in 3 ML Inhalation Solution

levalbuterol 0.417 MG/ML Inhalation Solution [Xopenex]


Neutracare 1.1 % Dental Gel
NeutraCare 1.1 % Oral Gel
Neutracare 0.011 MG/MG Oral Gel

sodium fluoride 0.011 MG/MG Oral Gel [Neutracare]


Catapres-TTS-3, 0.3 MG/Day 7 Day Transdermal Patch

Catapres-TTS-3, 0.3 MG/Day Weekly Transdermal System

168 HR Catapres-TTS-3 0.0125 MG/HR Transdermal System

168 HR cloNIDine 0.0125 MG/HR Transdermal System [Catapres]

168 HR Catapres 0.0125 MG/HR Transdermal System

168 HR clonidine 0.0125 MG/HR Transdermal System [Catapres]


72 HR Duragesic 0.1 MG/HR Transdermal System

Duragesic 100 MCG/HR 72HR Transdermal Patch

72 HR fentaNYL 0.1 MG/HR Transdermal System [Duragesic]

DURAGESIC 100 MCG/HR 72HR Transdermal System

72 HR fentanyl 0.1 MG/HR Transdermal System [Duragesic]


ACEON 8 MG Oral Tablet
Aceon 8 MG Oral Tablet

perindopril erbumine 8 MG Oral Tablet [Aceon]


risperiDONE 0.25 MG Oral Tablet [RisperDAL]

risperidone 0.25 MG Oral Tablet [Risperdal]


MIGRANAL 4 MG/mL Metered Dose Nasal Spray

Migranal 0.5 MG/ACTUAT Metered Dose Nasal Spray

DHE Mesylate 0.5 MG/ACTUAT Metered Dose Nasal Spray [Migranal]

Migranal 4 MG/ML Metered Dose Nasal Spray

dihydroergotamine mesylate 0.5 MG/ACTUAT Metered Dose Nasal Spray [Migranal]


progesterone 100 MG Oral Capsule [Prometrium]


OXcarbazepine 600 MG Oral Tablet [Trileptal]

oxcarbazepine 600 MG Oral Tablet [Trileptal]


Lipitor (as atorvastatin calcium) 80 MG Oral Tablet

atorvastatin 80 MG Oral Tablet [Lipitor]


Prevalite Sugar-Free 4000 MG Powder for Oral Suspension

Prevalite 4 GM Powder for Oral Suspension

Sugar-Free cholestyramine resin 4000 MG Powder for Oral Suspension [Prevalite]


Multitrace-5 Concentrate (chromic chloride 51.3 MCG (chromium 10 MCG) / copper sulfate 3.93 MG (copper 1 MG) / manganese sulfate 1.54 MG (manganese 0.5 MG) / selenious acid 98 MCG (selenium 60 MCG) / zinc sulfate 22 MG (zinc 5 MG)) per 1 ML Injectable Solution

Multitrace-5 (chromic chloride 0.0513 MG/ML / copper sulfate 3.93 MG/ML / manganese sulfate 1.54 MG/ML / selenious acid 0.098 MG/ML / zinc sulfate 22 MG/ML) Injectable Solution

chromic chloride 0.0513 MG/ML / Copper Sulfate 3.93 MG/ML / manganese sulfate 1.54 MG/ML / Selenious Acid 0.098 MG/ML / ZnSO4 22 MG/ML Injectable Solution [Multitrace-5]

Multitrace-5 Concentrate (chromic chloride 51.3 MCG (chromium 10 MCG) / copper sulfate 3.93 MG (copper 1 MG) / manganese sulfate 1.54 MG (manganese 0.5 MG) / selenious acid 98 MCG (selenium 60 MCG) / zinc sulfate 22 MG (zinc 5 MG)) in 1 mL Injectable Solution

chromic chloride 0.0513 MG/ML / copper sulfate 3.93 MG/ML / manganese sulfate 1.54 MG/ML / selenious acid 0.098 MG/ML / zinc sulfate 22 MG/ML Injectable Solution [Multitrace-5]


APAP 325 MG / Oxycodone Hydrochloride 5 MG Oral Tablet [Percocet]

Percocet 5/325 (oxyCODONE hydrochloride / APAP) Oral Tablet

APAP 325 MG / oxyCODONE Hydrochloride 5 MG Oral Tablet [Percocet]

acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet [Percocet]

acetaminophen 325 MG / oxyCODONE hydrochloride 5 MG Oral Tablet [Percocet]

Percocet 5/325 (oxycodone hydrochloride / APAP) Oral Tablet


Sea Soft 6.5 MG/ML Nasal Spray
Sea Soft 0.65 % Nasal Spray
NaCl 6.5 MG/ML Nasal Spray [Sea Soft]

sodium chloride 6.5 MG/ML Nasal Spray [Sea Soft]


Actiq (as fentaNYL citrate) 400 MCG Oral Lozenge

Actiq (as fentanyl citrate) 400 MCG Oral Lozenge


risperiDONE 0.5 MG Oral Tablet [RisperDAL]

risperidone 0.5 MG Oral Tablet [Risperdal]


benzoyl peroxide 30 MG/ML Medicated Liquid Soap [Triaz]


An immunoconjugate of the monoclonal antibody ibritumomab conjugated with the linker-chelator tiuxetan, a high affinity, conformationally restricted chelation site for radioisotopes. When bound to indium In 111 or yttrium Y 90, ibritumomab tiuxetan, targeting the CD20 antigen on B cell surfaces, specifically delivers a potentially cytotoxic dose of radiation to B lymphocytes. Ibritumomab is a murine IgG1 kappa monoclonal antibody directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes.


brand name of a high blood pressure medication


A murine IgG2 monoclonal antibody directed against the CD20 antigen, found on the surface of B-cells. Tositumomab binds to the CD20 surface membrane antigen, resulting in apoptosis, and may stimulate antitumoral cell-mediated and/or antibody-dependent cytotoxicity. (NCI04)


A human IgG2kappa monoclonal antibody specific for the epidermal growth factor receptor (EGFR). Monoclonal antibody E7.6.3 binds to the EGFR, blocking the binding of epidermal growth factor and transforming growth factor alpha to EGFR-expressing cancer cells and ultimately inhibiting EGFR-dependent cell activation and proliferation. (NCI)


The morpholinoethyl ester of mycophenolic acid (MPA). As an immunosuppressive agent in vivo, the active metabolite mycophenolate reversibly inhibits inosine 5'-monophosphate dehydrogenase (IMPDH), an enzyme involved in the de novo synthesis of guanine nucleotides, thereby retarding T-cell and B-cell proliferation. MPA displays high lymphocyte specificity and cytotoxicity because lymphocyte metabolism is highly dependent on both salvage and de novo synthesis of guanine nucleotides. (NCI04)


The alcoholic extract of the bulb or whole garlic plant Allium sativum (Liliaceae) with potential antineoplastic activity. The garlic plant has long been considered a beneficial plant for health and has been used as an antihelmintic, a rubefacient, an anti-infective, and an antihypertensive. Fresh or aged, garlic extracts contain compounds such as diallyl and allyl propyl disulfides with potent antioxidant, cholesterol-lowering properties; regular ingestion may be preventative for atherosclerosis and cardiovascular diseases. (NCI04)


Lactuca virosa extract
Lactuca virosa whole extract


The mesylate salt form of nelfinavir, a synthetic antiviral agent that selectively binds to and inhibits human immunodeficiency virus (HIV) protease. Nelfinavir has activity against HIV 1 and 2.


The hydrochloride salt of a semisynthetic derivative of camptothecin with antineoplastic activity. During the S phase of the cell cycle, topotecan selectively stabilizes topoisomerase I-DNA covalent complexes, inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when complexes are encountered by the DNA replication machinery. Camptothecin is a cytotoxic quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata.


A methylated tyrosine, a catecholamine synthesis antagonist with antihypertensive property. Metyrosine competitively inhibits tyrosine 3-monooxygenase, an enzyme that activates molecular oxygen to catalyze the hydroxylation of tyrosine to dihydroxyphenylalanine (Dopa), an intermediate to catecholamine (dopamine, norepinephrine, and epinephrine) production. This agent reduces the elevated levels of catecholamines associated with pheochromocytoma, thereby preventing hypertension.


The monohydrate form of azithromycin, an orally bioavailable azalide derived from erythromycin, and a member of a subclass of macrolide antibiotics, with anti-bacterial activity. Upon oral administration, azithromycin reversibly binds to the 23S rRNA of the 50S ribosomal subunit of the bacterial ribosome of susceptible microorganisms, thereby inhibiting the translocation step of protein synthesis by preventing the assembly of the 50S ribosomal subunit. This inhibits bacterial protein synthesis, inhibits cell growth and causes cell death.


The sodium salt form of nedocromil, a pyranoquinolone derivative with anti-inflammatory properties. Nedocromil sodium inhibits the activation and release of inflammatory mediators (leukotrienes, histamine and prostaglandins) from a variety of cells involved in hypersensitivity reactions, including mast cells, eosinophils, neutrophils, macrophages, monocytes and platelets. As a result, nedocromil sodium inhibits both immediate and late bronchoconstriction, decreases bronchial hyperresponsiveness and inhibits recruitment of other inflammatory cells into the airway epithelium.


The hydrochloride salt form of tocainide, a primary amine analog of lidocaine exhibiting class 1b antiarrhythmic property. Tocainide hydrochloride stabilizes the neuronal membrane by reversibly binding to and blocking open and inactivated voltage-gated sodium channels. This inhibits the inward sodium current required for the initiation and conduction of impulses and reduces the excitability of myocardial cells. This agent reduces the rate of rise and amplitude, and shortens the action-potential duration (APD) in both the Purkinje and muscle fibers. Tocainide also shortens the effective refractory period (ERP) of Purkinje fibers resulting in an increased the ERP/APD ratio. Overall these effects lead to the slowing of nerve impulses and stabilization of the heartbeat.


The anhydrous form of enalaprilat, a dicarbocyl-containing peptide and angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Enalaprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II and results in vasodilation. Enalaprilat also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow.


The sodium salt form of cefonicid, a semisynthetic second-generation cephalosporin with antibacterial activity. Cefonicid binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. PBPs are enzymes involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis.


2,4-dichlorophenoxyacetic acid, sodium salt


A stable coordination compound comprised of sodium valproate and valproic acid with anticonvulsant and antiepileptic activities. Divalproex dissociates to the valproate ion in the gastrointestinal tract. This agent binds to and inhibits gamma-aminobutyric acid (GABA) transaminase and its anticonvulsant activity may be exerted by increasing brain concentration of GABA and by inhibiting enzymes that catabolize GABA or block the reuptake of GABA into glia and nerve endings. Divalproex may also work by suppressing repetitive neuronal firing through inhibition of voltage-sensitive sodium channels.


The maleate salt form of pheniramine, an alkylamine derivative with antihistaminic and vasodilatory properties. Pheniramine maleate binds to histamine H1 receptors, thereby inhibiting phospholipase A2 and production of endothelium-derived relaxing factor, nitric oxide. Subsequent lack of activation of guanylyl cyclase through nitric oxide results in decreased cyclic GMP (cGMP) levels, thereby inhibiting constriction of smooth muscle tissue, and decreased capillary permeability and histamine-activated allergic reactions.


The hydrochloride salt of the substituted benzamide metoclopramide, a para-aminobenzoic acid (PABA) derivative that is structurally related to procainamide, with gastroprokinetic and antiemetic activities. Metoclopramide binds to dopamine 2 (D2) receptors in the peripheral nervous system (PNS), antagonizing dopamine-mediated relaxation of gastrointestinal smooth muscle and promoting gastroprokinesis; the pyloric sphincter and the duodenal bulb are relaxed, peristalsis of the duodenum and jejunum increase, and gastric emptying and intestinal transit accelerate. This agent may also increase the resting tone of the lower esophagus sphincter (LES), preventing acid reflux. In the central nervous system (CNS), metoclopramide antagonizes D2 dopamine receptors in the chemoreceptive trigger zone (CTZ) of the medulla, thereby preventing nausea and vomiting.


The sodium salt form of methicillin, a semisynthetic beta-lactam penicillin antibiotic with beta-lactamase resistant activity. Methicillin sodium is bactericidal and binds to specific penicillin-binding proteins on the bacterium and inhibits the transpeptidation enzyme, thereby preventing the cross-linking of peptidoglycans. This leads to an interruption of the bacterial cell wall and causes bacterial lysis. Methicillin sodium is active against beta-lactamase producing staphylococci.


The sodium salt form of ibuprofen, a propionic acid derivate and nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic activities. Upon administration, ibuprofen inhibits the activity of cyclo-oxygenase I and II, resulting in a decreased formation of precursors of prostaglandins and thromboxanes. This leads to decreased prostaglandin synthesis, by prostaglandin synthase, the main physiologic effect of ibuprofen. Ibuprofen also causes a decrease in the formation of thromboxane A2 synthesis, by thromboxane synthase, thereby inhibiting platelet aggregation.


The calcium salt form of fenoprofen, a propionic acid derivative with analgesic, non-steroidal antiinflammatory and antirheumatic properties. Fenoprofen inhibits both isozymes of cyclooxygenase; resulting in prostaglandin synthesis inhibition, thereby blocking the conversion of arachidonic acid to prostaglandins. In addition, fenoprofen activate both peroxisome proliferator activated receptors (PPAR)-alpha and -gamma, by which it may down-regulate leukotriene B4 production.


The sodium salt form of dicloxacillin, a broad-spectrum, semi-synthetic beta-lactam with bactericidal and beta-lactamase resistant activity. Dicloxacillin sodium binds to penicillin binding proteins (PBP) located on the inner membrane of the bacterial cell wall. It also inhibits the cross-linkage of peptidoglycan, a critical component of bacterial cell walls. This leads to the inhibition of bacterial cell wall synthesis and eventually causes cell lysis.


The hydrochloride salt form of spectinomycin, an aminocyclitol antibiotic derived from Streptomyces spectabilis with antibacterial property. Spectinomycin hydrochloride binds to the bacterial 30S ribosomal subunit, thereby inhibiting peptide elongation and protein synthesis, consequently leading to bacterial cell death.


The sodium salt form of a broad-spectrum, semisynthetic aminopenicillin antibiotic with bactericidal activity. Amoxicillin binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This interrupts bacterial cell wall synthesis and results in the weakening of the bacterial cell wall and causes cell lysis.


A long-acting, amide-type local anesthetic. Bupivicaine reversibly binds to specific sodium ion channels in the neuronal membrane, resulting in a decrease in the voltage-dependent membrane permeability to sodium ions and membrane stabilization; inhibition of depolarization and nerve impulse conduction; and a reversible loss of sensation.


The sodium salt form of cefsuldin, a semi-synthetic, third-generation cephalosporin antibiotic with a narrow spectrum of activity. Cefsulodin has activity against Pseudomonas aeruginosa and Staphylococcus aureus but little activity against other bacteria.


The anhydrous, sodium salt form of acetic acid. Sodium acetate anhydrous disassociates in water to form sodium ions (Na+) and acetate ions. Sodium is the principal cation of the extracellular fluid and plays a large part in fluid and electrolyte replacement therapies. Sodium acetate anhydrous is used as an electrolyte replenisher in isosmotic solution for parenteral replacement of acute losses of extracellular fluid without disturbing normal electrolyte balance.


The sodium salt form of azathioprine, a pro-drug of purine analogue with immunosuppressive activity. Azathioprine is converted in vivo to its active metabolite 6-mercaptopurine (6-MP), which substitutes for the normal nucleoside and mistakenly gets incorporated into DNA sequences. This leads to inhibition of DNA, RNA, and protein synthesis. As a result, cell proliferation may be inhibited, particularly in lymphocytes and leukocytes.


A poorly adsorbed analog of prednisolone, a synthetic glucocorticoid with anti-inflammatory and immunomodulating properties. After cell surface receptor attachment and cell entry, prednisolone enters the nucleus where it binds to and activates specific nuclear receptors, resulting in an altered gene expression and inhibition of proinflammatory cytokine production. This agent also decreases the number of circulating lymphocytes, induces cell differentiation, and stimulates apoptosis in sensitive tumor cells populations. (NCI)


The citrate salt of the radioisotope gallium Ga 67. Although the mechanism is unknown, gallium Ga 67 concentrates in lysosomes and is bound to a soluble intracellular protein in certain viable primary and metastatic tumors and focal sites of inflammation, allowing scintigraphic localization. Ga-67 scintigraphy (GS) cannot differentiate between tumor and acute inflammation.


A functionalized amino acid compound specifically synthesized as an anticonvulsive drug to use as add-on therapy for partial-onset seizures with antinociceptive and neuroprotective activities. Lacosamide selectively enhances slow inactivation of voltage-gated sodium channels without affecting fast inactivation, thereby stabilizing hyperexcitabe neuronal membranes. Furthermore, this agent binds to collapsin response mediator protein 2 (CRMP2; DPYSL2), a cytosolic phosphoprotein expressed in most tissues. In the nervous system, CRMP2 acts as a mediator of growth cone collapse as well as modifies axon number, length, and neuronal polarity.


An orally bioavailable 8-aminoquinoline derivative, with antimalarial activity. Although the mechanism is not completely understood, upon administration, tafenoquine inhibits the parasitic enzyme heme polymerase in the blood stages of the parasites. This inhibits the conversion of the toxic heme into non-toxic hemazoin, thereby resulting in the accumulation of toxic heme within the parasite. Tafenoquine is active against all the stages of Plasmodium species and is also active against the pre-erythrocytic liver stages of the parasites. This prevents the development of the erythrocytic forms of the parasite which are responsible for relapses in P. vivax malaria.


A phenylalanine derivative of the meglitinide class of agents with hypoglycemic activity. Nateglinide, compared to repaglitinide, binds with a higher affinity to the SUR1 subunit and with a faster onset of action and a shorter duration of action. This agent is metabolized by the cytochrome P450 isoenzyme CYP2C9, and, to a lesser extent, by CYP3A4. The parent drug and metabolites are mainly excreted in the urine and its half-life is about 1.5 hours.


Recombinant form of endogenous Insulin-like Growth Factor 1 exhibiting mitogenic activity. Clinical Use: Diabetes Mellitus and Amyotrophic Lateral Sclerosis.


An arabinonucleoside antimetabolite with antineoplastic activity. Nelarabine is demethoxylated by adenosine deaminase to become biologically active 9-beta-D-arabinosylguanine (ara-G); ara-G incorporates into DNA, thereby inhibiting DNA synthesis and inducing an S phase-dependent apoptosis of tumor cells. (NCI04)


A recombinant human insulin analog with long-acting, blood glucose-lowering activity. Insulin glargine, like regular types of human insulin, regulates glucose metabolism by binding to insulin receptors on muscle and fat cells, thereby facilitating the cellular uptake of glucose. This lowers blood glucose levels. At the same time, insulin glargine inhibits the liver's conversion of stored glycogen into glucose, which also contributes to lower blood glucose levels. Insulin glargine also inhibits lipolysis in adipose tissue, inhibits proteolysis, and enhances protein synthesis. (NCI05)


A nonhalogenated, synthetic, inhaled corticosteroid (ICS) with anti-inflammatory and potential antiviral activities. Upon administration by oral inhalation into the lungs, ciclesonide (CIC) is converted by local esterases to its active metabolite desisobutyryl-ciclesonide (des-CIC), which binds to intracellular glucocorticoid receptors (GRs). The ligand-bound GRs regulate gene expressions, which lead to inhibitory activities against multiple cell types, such as mast cells, eosinophils, basophils, lymphocytes, macrophages and neutrophils, and various mediators associated with inflammation, such as histamine, eicosanoids, leukotrienes and cytokines. In addition, ciclesonide may suppress the replication of human coronavirus by targeting viral nonstructural protein 15 (NSP15).


A long-acting piperidine derivate with selective H1 antihistaminergic and non-sedating properties. Desloratadine diminishes the typical histaminergic effects on H1-receptors in bronchial smooth muscle, capillaries and gastrointestinal smooth muscle, including vasodilation, bronchoconstriction, increased vascular permeability, pain, itching and spasmodic contractions of gastrointestinal smooth muscle. Desloratadine is used to provide symptomatic relieve of allergic symptoms.


A ganciclovir prodrug and antiviral agent that is used to treat CYTOMEGALOVIRUS RETINITIS in patients with AIDS, and for the prevention of CYTOMEGALOVIRUS INFECTIONS in organ transplant recipients who have received an organ from a CMV-positive donor.


A synthetic fluoro derivative of thiacytidine with potent antiviral activity. Emtricitabine is phosphorylated to form emtricitabine 5'-triphosphate within the cell. This metabolite inhibits the activity of human immunodeficiency virus (HIV) reverse transcriptase both by competing with the natural substrate deoxycytidine 5'-triphosphate and by incorporation into viral DNA causing a termination of DNA chain elongation (due to the lack of the essential 3'-OH group).


5,7,4'-trihydroxy-flavone, one of the FLAVONES.


A sulfonamide derivative and non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic activities. Valdecoxib selectively binds to and inhibits cyclooxygenase (COX)-2, thereby preventing the conversion of arachidonic acid into prostaglandins, which are involved in the regulation of pain, inflammation, and fever. This NSAID does not inhibit COX-1 at therapeutic concentrations and therefore does not interfere with blood coagulation.


A pegylated, recombinant, human growth hormone (GH) structural analog with GH receptor antagonist activity. As a GH analog, the structure of pegvisomant is similar to that of native GH with the exception of 9 amino acid substitutions. Pegvisomant selectively binds to GH receptors on cell surfaces, interfering with endogenous GH receptor binding and so GH signal transduction. Inhibition of GH signal transduction results in decreased serum concentrations of insulin-like growth factor-I (IGF-I), and other GH-responsive serum proteins, including IGF binding protein-3 (IGFBP-3) and the acid-labile subunit (ALS), and may inhibit the growth of cancers in which IGF-1 is upregulated.


A sulfonamide triptan with extracerebral, intracranial vasoconstrictor activity. Almotriptan selectively binds to and activates serotonin 5-HT 1B and 1D receptors in the central nervous system (CNS), thereby causing extracerebral, intracranial blood vessel constriction. This may lead to pain relief from vascular headaches. Almotriptan may also relieve vascular headaches by preventing the release of vasoactive neuropeptides from perivascular trigeminal axons in the dura mater during a migraine, by reducing extravasation of plasma proteins, and by decreasing the release of other mediators of inflammation from the trigeminal nerve.


An amide prodrug of the cyclooxygenase II (COX-2) selective, non-steroidal anti-inflammatory drug (NSAID) valdecoxib, with anti-inflammatory, analgesic, and antipyretic activities. Upon administration, parecoxib is hydrolyzed by hepatic carboxyesterases to its active form, valdecoxib. Valdecoxib selectively binds to and inhibits COX-2. This prevents the conversion of arachidonic acid into prostaglandins, which are involved in the regulation of pain, inflammation, and fever. This NSAID does not inhibit COX-1 at therapeutic concentrations and, therefore, does not interfere with blood coagulation.


A water-soluble, injectable sodium salt form of parecoxib, an amide prodrug of the cyclooxygenase II (COX-2) selective, non-steroidal anti-inflammatory drug (NSAID) valdecoxib, with anti-inflammatory, analgesic, and antipyretic activities. Upon intravenous or intramuscular administration, parecoxib is hydrolyzed by hepatic carboxyesterases to its active form, valdecoxib. Valdecoxib selectively binds to and inhibits COX-2. This prevents the conversion of arachidonic acid into prostaglandins, which are involved in the regulation of pain, inflammation, and fever. This NSAID does not inhibit COX-1 at therapeutic concentrations and, therefore, does not interfere with blood coagulation.


A second generation, synthetic, low-molecular-weight heparin (LMWH) with anticoagulant activity. Derived, after depolymerisation and fractionation, from medical-grade porcine unfractionated heparin (UFH), bemiparin has an average molecular weight of 3,600 daltons and has a higher anti-factor Xa/anti-factor IIa ratio (8:1) than first-generation LMWHs. This anticoagulant binds to antithrombin III, thereby enhancing the inactivation of activated factor X (Factor Xa) and, to a lesser extent, activated factor II (Factor IIa). Compared to unfractionated heparins, the use of bemiparin is associated with lower incidences of major bleeding, osteoporosis, and heparin-induced thrombocytopenia. Bemiparin also promotes a greater release of tissue factor pathway inhibitor than UFH or dalteparin.


The chloride salt of a radioactive isotope of strontium. Strontium chloride Sr 89 is taken up and incorporated preferentially in metastatic lesions in bone where it emits cytotoxic beta radiation, resulting in an inhibition and/or reduction of tumor growth and so tumor-related bone pain. (NCI04)


The hydrochloride salt form of cephalexin, a beta-lactam, first-generation cephalosporin antibiotic with bactericidal activity. Cephalexin hydrochloride binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. PBPs participate in the terminal stages of assembling the bacterial cell wall, and in reshaping the cell wall during cell division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis.


A sphingomyelin/cholesterol liposomal formulation of vincristine sulfate with potential antineoplastic activity. Vincristine, a vinca alkaloid isolated from the plant Vinca rosea, irreversibly binds to and stabilizes tubulin, thereby interrupting microtubule assembly/disassembly dynamics, thereby preventing the formation of the mitotic spindle and leading to cell cycle arrest in metaphase. Liposomal encapsulation prolongs bioavailability of vincristine, increases its delivery to tumor tissues and reduces its toxicity profile. Compared to standard liposomal delivery, sphingosomal drug delivery further increases circulation time of serum drug and enhances drug accumulation at tumor sites, thereby leading to a further increase in efficacy.


An estradiol derivative and estrogen receptor antagonist that is used for the treatment of estrogen receptor-positive, locally advanced or metastatic breast cancer.


The acetate salt of an antimycotic echinocandin lipopeptide, semisynthetically derived from a fermentation product of the fungus Glarea lozoyensis. Caspofungin inhibits 1,3-beta-glucan synthase, resulting in decreased synthesis of beta(1,3)-D-glucan (an essential component of the fungal cell wall), weakening of the fungal cell wall, and fungal cell wall rupture. This agent is active against Aspergillus and Candida species.


An antineoplastic agent that inhibits the Bcr-Abl fusion protein tyrosine kinase, an abnormal enzyme produced by chronic myeloid leukemia cells that contain the Philadelphia chromosome. Imatinib also inhibits the receptor tyrosine kinases for platelet-derived growth factor (PDGF) and stem cell factor (SCF)/c-kit; the SCF/c-kit receptor tyrosine kinase is activated in gastrointestinal stromal tumor (GIST). This agent inhibits proliferation and induces apoptosis in cells that overexpress these oncoproteins.


vitamin C 500 MG Oral Tablet
vit-C 500 MG Oral Tablet


The hydrochloride salt of amantadine, a synthetic tricyclic amine with antiviral, antiparkinsonian, and antihyperalgesic activities. Amantadine appears to exert its antiviral effect against the influenza A virus by interfering with the function of the transmembrane domain of the viral M2 protein, thereby preventing the release of infectious viral nucleic acids into host cells; furthermore, this agent prevents virus assembly during virus replication. Amantadine exerts its antiparkinsonian effects by stimulating the release of dopamine from striatal dopaminergic nerve terminals and inhibiting its pre-synaptic reuptake. This agent may also exert some anticholinergic effect through inhibition of N-methyl-D-aspartic acid (NMDA) receptor-mediated stimulation of acetylcholine, resulting in antihyperalgesia.


The sodium salt form of thiopental, an ultrashort-acting barbituric acid derivative, with anesthetic activity. Thiopental binds to the chloride ionophore site of the gamma-aminobutyric acid (GABA)-A/chloride ionophore receptor complex, thereby enhancing the inhibitory actions of GABA-A in the brain. This leads to synaptic inhibition, decreased neuronal excitability and induction of anesthesia. In addition, this agent decreases glutamate (Glu) responses.


The disodium salt of a synthetic pyrimidine-based antifolate. Pemetrexed binds to and inhibits the enzyme thymidylate synthase (TS) which catalyses the methylation of 2'-deoxyuridine-5'-monophosphate (dUMP) to 2'-deoxythymidine-5'-monophosphate (dTMP), an essential precursor in DNA synthesis.


A broad-spectrum, second generation, triazole compound with antifungal activity. Posaconazole strongly inhibits 14-alpha demethylase, a cytochrome P450-dependent enzyme. Inhibition of 14-alpha-demethylase prevents the conversion of lanosterol to ergosterol, an important component of the fungal cell wall. Inhibition of ergosterol synthesis changes the fungal cell membrane composition and integrity, alters membrane permeability and eventually leads to fungal cell lysis. Compared to other azole antifungals, posaconazole is a significantly more potent inhibitor of sterol 14-alpha demethylase.


Drug combination of artemether and lumefantrine that is used to treat PLASMODIUM FALCIPARUM MALARIA.


cysteine HCl 50 MG/ML Injectable Solution

cysteine hydrochloride 50 MG/ML Injectable Solution


HYDROmorphone HCl 4 MG in 1 ML Injection

HYDROmorphone HCl 4 MG per 1 ML Injection

1 ML HYDROmorphone hydrochloride 4 MG/ML Injection

1 ML hydromorphone hydrochloride 4 MG/ML Injection

hydromorphone HCl 4 MG per 1 ML Injection


prilocaine hydrochloride 4 % Injectable Solution

prilocaine hydrochloride 40 MG/ML Injectable Solution


PHENobarbital 30 MG/ML Injectable Solution

phenobarbital 30 MG/ML Injectable Solution


PHENobarbital 60 MG/ML Injectable Solution

phenobarbital 60 MG/ML Injectable Solution


calcium carbonate 1250 MG (calcium 500 MG) Oral Tablet

calcium 500 MG Oral Tablet, as calcium carbonate


bupivacaine HCl 0.25 % Injectable Solution

bupivacaine hydrochloride 0.25 % Injectable Solution

bupivacaine hydrochloride 2.5 MG/ML Injectable Solution


bupivacaine hydrochloride 0.5 % Injectable Solution

bupivacaine hydrochloride 5 MG/ML Injectable Solution

bupivacaine HCl 0.5 % Injectable Solution


enoxaparin sodium 100 MG/ML Injectable Solution

ENX sodium 100 MG/ML Injectable Solution


bumetanide 0.25 MG/ML Injectable Solution


typhoid Vi polysaccharide vaccine (generic for Typhim Vi) Injectable Solution

typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 25 MCG per 0.5 ML Injectable Solution

typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Injectable Solution


magnesium oxide 600 MG (magnesium 362 MG) / pyridoxine HCl 25 MG (vitamin B6 20 MG) Oral Tablet

magnesium 362 MG / vitamin B6 20 MG Oral Tablet

Magnesium Oxide 600 MG / vitamin B6 Hydrochloride 25 MG Oral Tablet

magnesium oxide 600 MG / pyridoxine hydrochloride 25 MG Oral Tablet

Magnesium Oxide 600 MG / vit-B6 Hydrochloride 25 MG Oral Tablet


methoxsalen 20 MCG/ML Injectable Solution

methoxsalen 0.02 MG/ML Injectable Solution


camphor 2 % / eucalyptus oil 5 % / methyl salicylate 2 % Topical Ointment

camphor 0.02 MG/MG / Eucalyptus oil 0.05 MG/MG / methyl salicylate 0.02 MG/MG Topical Ointment


camphor 2 % / menthol 1 % / methyl salicylate 4.9 % Topical Lotion

camphor 20 MG/ML / menthol 10 MG/ML / methyl salicylate 49 MG/ML Topical Lotion


wasp venom protein 0.1 MG/mL Injectable Solution

mixed Polistes species venom protein 0.1 MG/ML Injectable Solution

wasp venom protein 0.1 MG/ML Injectable Solution


bald-faced hornet venom protein 0.1 MG/mL / common wasp venom protein 0.02 MG/mL / eastern yellow jacket venom protein 0.02 MG/mL / German wasp venom protein 0.02 MG/mL / southern yellow jacket venom protein 0.02 MG/mL / western yellow jacket venom protein 0.02 MG/mL / yellow hornet venom protein 0.1 MG/mL Injectable Solution

Dolichovespula maculata venom protein 100 MCG / Vespula vulgaris venom protein 20 MCG / Vespula maculifrons venom protein 20 MCG / Vespula germanica venom protein 20 MCG / Vespula squamosa venom protein 20 MCG / Vespula pensylvanica venom 20 MCG / Dolichovespula arenaria venom protein 100 MCG per 1 ML Powder for Injectable Solution

bald-faced hornet venom protein 0.1 MG/ML / common wasp venom protein 0.02 MG/ML / eastern yellow jacket venom protein 0.02 MG/ML / German wasp venom protein 0.02 MG/ML / southern yellow jacket venom protein 0.02 MG/ML / western yellow jacket venom protein 0.02 MG/ML / yellow hornet venom protein 0.1 MG/ML Injectable Solution


doxercalciferol 0.002 MG/ML Injectable Solution

doxercalciferol 2 MCG/ML Injectable Solution


oxyCODONE hydrochloride 30 MG Oral Tablet

oxycodone hydrochloride 30 MG Oral Tablet


calamine 8 % / phenol 1 % Topical Lotion

calamine 80 MG/ML / phenol 10 MG/ML Topical Lotion


camphor 9 % / menthol 1.35 % Topical Ointment

camphor 0.09 MG/MG / menthol 0.0135 MG/MG Topical Ointment


psyllium 6 GM Powder for Oral Suspension

psyllium 6000 MG Powder for Oral Suspension


monofluorophosphate, sodium 0.15 % Toothpaste

monofluorophosphate 0.0015 MG/MG Toothpaste


evening primrose oil 1000 MG Oral Capsule


evening primrose oil 1300 MG Oral Capsule


salicylic acid 2.5 GM per 100 GM Topical Cream


Lactobacillus acidophilus 12.4 billion UNT per 5 ML Oral Powder for Suspension

Lactobacillus acidophilus 2480000000 MG/ML Oral Suspension


calcium carbonate 220 MG Chewable Tablet


Lactobacillus acidophilus 1 Billion UNT Oral Capsule

Lactobacillus acidophilus 1000000000 UNT Oral Capsule


NaCl 30 MG/ML Nasal Spray
sodium chloride 3 % Nasal Spray


sodium phosphate, dibasic 2.7 GM / sodium phosphate, monobasic 7.2 GM per 15 ML Oral Solution

sodium phosphate, dibasic 2.7 GM / sodium phosphate, monobasic 7.2 GM in 15 mL Oral Solution

sodium phosphate, dibasic 180 MG/ML / sodium phosphate, monobasic 480 MG/ML Oral Solution


iodine 2 % / potassium iodide 2.4 % Topical Solution

Iodine 20 MG/ML / K+ Iodide 24 MG/ML Topical Solution

Iodine 20 MG/ML / Pot Iodide 24 MG/ML Topical Solution

iodine 20 MG/ML / potassium iodide 24 MG/ML Topical Solution


vit-C 4000 MG Powder for Oral Suspension

vitamin C 4000 MG Powder for Oral Suspension

vitamin C 4 GM Powder for Oral Suspension

ascorbic acid 4000 MG Powder for Oral Suspension


APAP 250 MG / Magnesium Salicylate 250 MG / pamabrom 25 MG Oral Tablet

acetaminophen 250 MG / magnesium salicylate 250 MG / pamabrom 25 MG Oral Tablet


Lactobacillus acidophilus 200 Million UNT Oral Tablet

Lactobacillus acidophilus 200000000 UNT Oral Tablet


benzocaine 20 % / menthol 0.95 % Topical Swab

benzocaine 20 % / menthol 0.95 % Medicated Pad

benzocaine 200 MG/ML / menthol 9.5 ML/ML Medicated Pad


vitamin E 1150 UNT in 1.25 mL Oral Solution

vitamin E 1150 UNT per 1.25 ML Oral Solution


magnesium citrate 1.745 GM in 1 FL OZ Oral Solution

magnesium citrate 1.745 GM per 30 ML Oral Solution

magnesium citrate 1.745 GM per 29.6 ML Oral Solution

magnesium citrate 1.745 GM per 1 FL OZ Oral Solution

magnesium citrate 58.2 MG/ML Oral Solution


menthol 10 % / methyl salicylate 15 % Topical Gel

menthol 0.1 MG/MG / methyl salicylate 0.15 MG/MG Topical Gel


menthol 6 % / methyl salicylate 20 % Topical Lotion

menthol 60 MG/ML / methyl salicylate 200 MG/ML Topical Lotion


quercetin 50 MG / vitamin B5 100 MG / vitamin C 100 MG Oral Tablet

vitamin C 100 MG / Pantothenic Acid 100 MG / Quercetin 50 MG Oral Tablet

vit-C 100 MG / Pantothenic Acid 100 MG / Quercetin 50 MG Oral Tablet

ascorbate calcium 100 MG / calcium pantothenate 100 MG / quercetin 50 MG Oral Tablet

ascorbic acid 100 MG / pantothenic acid 100 MG / quercetin 50 MG Oral Tablet


camphor 3.1 % / menthol 16 % / methyl salicylate 10 % Topical Gel

camphor 0.031 MG/MG / menthol 0.16 MG/MG / methyl salicylate 0.1 MG/MG Topical Gel


benzethonium Cl 0.2 % / dyclonine HCl 0.75 % Topical Solution

benzethonium chloride 2 MG/ML / dyclonine hydrochloride 7.5 MG/ML Topical Solution


iodine 6 % / methyl salicylate 4.8 % Topical Ointment

iodine 0.06 MG/MG / methyl salicylate 0.048 MG/MG Topical Ointment


phosphorus (as dicalcium phosphate) 68 MG / cyanocobalamin 2 MG Oral Tablet

dicalcium phosphate 68 MG / vitamin B12 2 MG Oral Tablet


sodium phosphate monobasic 1.102 GM / sodium phosphate dibasic 0.398 GM Oral Tablet

sodium phosphate, dibasic 398 MG / sodium phosphate, monobasic 1100 MG Oral Tablet


povidone-iodine 7.5 % (titratable iodine 0.75 % ) Topical Swab


Lactobacillus acidophilus 100 MG Oral Wafer


prednisoLONE 15 MG per 5 ML Oral Solution

prednisolone 15 MG per 5 ML Oral Solution

prednisoLONE sodium phosphate 15 MG in 5 mL Oral Solution

prednisolone 15 MG (as prednisolone sodium phosphate 20.2 MG) per 5 ML Oral Solution

prednisoLONE 15 MG (as prednisoLONE sodium phosphate 20.2 MG) per 5 ML Oral Solution


boric acid 11.1 MG/ML Ophthalmic Solution


camphor 40 MG/ML / menthol 100 MG/ML / methyl salicylate 300 MG/ML Topical Cream

camphor 4 % / menthol 10 % / methyl salicylate 30 % Topical Cream


nicotinic acid 0.2 MG / Riboflavin 0.02 MG / vitamin B1 0.06 MG Oral Tablet

nicotinic acid 0.2 MG / Riboflavin 0.02 MG / vit-B1 0.06 MG Oral Tablet

vit-B3 0.2 MG / Riboflavin 0.02 MG / vit-B1 0.06 MG Oral Tablet

vitamin B3 0.2 MG / Riboflavin 0.02 MG / vit-B1 0.06 MG Oral Tablet

vit-B3 0.2 MG / Riboflavin 0.02 MG / vitamin B1 0.06 MG Oral Tablet

vitamin B3 0.2 MG / Riboflavin 0.02 MG / vitamin B1 0.06 MG Oral Tablet

niacin 0.2 MG / riboflavin 0.02 MG / thiamine 0.06 MG Oral Tablet


DHA 120 MG / EPA 180 MG / vitamin E 5 UNT Oral Capsule

docosahexaenoic acid 120 MG / eicosapentaenoic acid 180 MG / vitamin E 5 UNT Oral Capsule


evening primrose oil 365 MG / gamma linolenic acid 45 MG Oral Capsule

evening primrose oil 365 MG / gamma-linolenate 45 MG Oral Capsule


sodium phosphate, dibasic 59.3 MG/ML / sodium phosphate, monobasic 161 MG/ML Enema

sodium phosphate, dibasic 7 GM / sodium phosphate, monobasic 19 GM per 118 ML Enema

sodium phosphate, dibasic 7 GM / sodium phosphate, monobasic 19 GM in 118 ML Enema

sodium phosphate, dibasic 3.5 GM / sodium phosphate, monobasic 9.5 GM per 59 ML Enema


indinavir 100 MG (indinavir sulfate 125 MG) Oral Capsule


guaiacol 2 % / methyl salicylate 8 % Topical Ointment

guaiacol 0.02 MG/MG / methyl salicylate 0.08 MG/MG Topical Ointment


vitamin C 200 MG / hesperidin 200 MG Oral Tablet

vit-C 200 MG / Hesperidin 200 MG Oral Tablet

ascorbic acid 200 MG / hesperidin 200 MG Oral Tablet


alpha-d-galactosidase enzyme 150 UNT Chewable Tablet

alpha-D-galactosidase enzyme 150 UNT Chewable Tablet


docosahexaenoic acid 120 MG / eicosapentaenoic acid 180 MG Oral Capsule


calcium glycerophosphate 333 MG Oral Tablet


benzalkonium chloride 0.2 % Topical Spray

benzalkonium chloride 2 MG/ML Topical Spray


chlorpheniramine maleate 2 MG / guaiFENesin 100 MG / phenylephrine hydrochloride 5 MG Oral Tablet

chlorpheniramine maleate 2 MG / guaiFENesin 100 MG / phenylephrine HCl 5 MG Oral Tablet

chlorpheniramine maleate 2 MG / guaifenesin 100 MG / phenylephrine hydrochloride 5 MG Oral Tablet


camphor 3.6 % / capsicum extract 0.25 % / methyl salicylate 15 % Topical Solution

camphor 36 MG/ML / Capsicum extract 2.5 MG/ML / methyl salicylate 150 MG/ML Topical Solution


Pot Chloride 50 MG / NaCl 180 MG Oral Tablet

potassium chloride 50 MG / sodium chloride 180 MG Oral Tablet

K+ Chloride 50 MG / NaCl 180 MG Oral Tablet


piperonyl butoxide 3 % / pyrethrins 0.3 % Medicated Shampoo

piperonyl butoxide 30 MG/ML / pyrethrins 3 MG/ML Medicated Shampoo


piperonyl butoxide 40 MG/ML / pyrethrins 3.3 MG/ML Medicated Shampoo

piperonyl butoxide 4 % / pyrethrins 0.33 % Medicated Shampoo


capsaicin 0.025 % / menthol 1 % / methyl salicylate 12 % Topical Cream

capsaicin 0.25 MG/ML / menthol 10 MG/ML / methyl salicylate 120 MG/ML Topical Cream


sodium chloride 0.69 % Nasal Spray
NaCl 6.9 MG/ML Nasal Spray


menthol 8.4 % / methyl salicylate 0.6 % / methylnicotinate 15 % Topical Spray

menthol 8.4 % / methylnicotinate 15 % / methyl salicylate 0.6 % Topical Spray

menthol 84 MG/ML / methyl salicylate 6 MG/ML / methylnicotinate 150 MG/ML Topical Spray


capsaicin 0.025 % / menthol 10 % / methyl salicylate 15 % Topical Cream

capsaicin 0.25 MG/ML / menthol 100 MG/ML / methyl salicylate 150 MG/ML Topical Cream


APAP 250 MG / Caffeine 50 MG / Magnesium Salicylate 290 MG Oral Tablet

acetaminophen 250 MG / caffeine 50 MG / magnesium salicylate 290 MG Oral Tablet


lactic acid 14 % / resorcinol 14 % / salicylic acid 14 % Topical Solution

lactic acid 140 MG/ML / resorcinol 140 MG/ML / salicylic acid 140 MG/ML Topical Solution


vitamin C 1000 MG Powder for Oral Suspension

vit-C 1000 MG Powder for Oral Suspension

ascorbic acid 1000 MG Powder for Oral Suspension


vit-C 200 MG Oral Tablet
ascorbic acid 200 MG Oral Tablet
vitamin C 200 MG Oral Tablet


vit-C 500 MG / Vitamin E 400 UNT Oral Capsule

ascorbic acid 500 MG / vitamin E 400 UNT Oral Capsule

vitamin C 500 MG / vitamin E 400 UNT Oral Capsule


hydroCHLOROthiazide 12.5 MG / telmisartan 40 MG Oral Tablet

HCTZ 12.5 MG / telmisartan 40 MG Oral Tablet

telmisartan 40 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet

hydrochlorothiazide 12.5 MG / telmisartan 40 MG Oral Tablet


HCTZ 12.5 MG / telmisartan 80 MG Oral Tablet

telmisartan 80 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet

hydroCHLOROthiazide 12.5 MG / telmisartan 80 MG Oral Tablet

hydrochlorothiazide 12.5 MG / telmisartan 80 MG Oral Tablet


hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet


sodium chloride 3 % Nasal Solution
NaCl 30 MG/ML Nasal Solution


Lactobacillus acidophilus 1 Billion UNT Oral Tablet

Lactobacillus acidophilus 1000000000 UNT Oral Tablet


amiodarone hydrochloride 400 MG Oral Tablet


rimabotulinumtoxinB 2500 UNT in 0.5 ML Injection

rimabotulinumtoxinB 2500 UNT per 0.5 ML Injection

0.5 ML rimabotulinumtoxinB 5000 UNT/ML Injection


glycerin 95 % / phenol 5 % Otic Solution

glycerin 950 MG/ML / phenol 50 MG/ML Otic Solution


cetrorelix (as cetrorelix acetate) 0.25 MG Injection


mirtazapine 15 MG Disintegrating Oral Tablet


mirtazapine 30 MG Disintegrating Oral Tablet


isopropyl alcohol 0.7 ML/ML Topical Spray


hydrogen peroxide 30 MG/ML Topical Spray


ascorbic acid 500 MG / vitamin E 200 UNT Oral Capsule

vitamin C 500 MG / vitamin E 200 UNT Oral Capsule

vit-C 500 MG / Vitamin E 200 UNT Oral Capsule


levonorgestrel 52 MG 5 Year Intrauterine System

levonorgestrel 52 MG Intrauterine System

levonorgestrel 20 MCG per 24 HR Intrauterine System

levonorgestrel 0.000833 MG/HR Intrauterine System


camphor 0.5 % / petrolatum 61.93 % Topical Ointment

camphor 0.005 MG/MG / petrolatum 0.619 MG/MG Topical Ointment


benzethonium Cl 0.2 % / lidocaine 4 % Topical Spray

benzethonium chloride 2 MG/ML / lidocaine 40 MG/ML Topical Spray


benzethonium Cl 0.2 % / benzocaine 3.2 % Topical Spray

benzethonium chloride 2 MG/ML / benzocaine 32 MG/ML Topical Spray


camphor 5.2 % / eucalyptus oil 1.2 % / menthol 2.8 % Topical Cream

camphor 52 MG/ML / Eucalyptus oil 12 MG/ML / menthol 28 MG/ML Topical Cream


24 HR metoprolol succinate 25 MG (as metoprolol succinate 23.75 MG equivalent to 25 MG metoprolol tartrate) Extended Release Oral Tablet

metoprolol succinate 25 MG 24HR Extended Release Oral Tablet

metoprolol succinate 25 MG 24 HR Extended Release Oral Tablet

24 HR metoprolol succinate 25 MG Extended Release Oral Tablet


witch hazel 50 % Medicated Pad
witch hazel 500 MG/ML Medicated Pad


camphor 5.1 % / menthol 5.1 % Topical Cream

camphor 51 MG/ML / menthol 51 MG/ML Topical Cream


mirtazapine 45 MG Disintegrating Oral Tablet


busPIRone HCl 7.5 MG (busPIRone 6.9 MG) Oral Tablet

busPIRone hydrochloride 7.5 MG Oral Tablet

buspirone HCl 7.5 MG (buspirone 6.9 MG) Oral Tablet

buspirone hydrochloride 7.5 MG Oral Tablet


carboxymethylcellulose sodium 0.25 % Ophthalmic Solution

carboxymethylcellulose sodium 2.5 MG/ML Ophthalmic Solution


ketorolac tromethamine 30 MG/ML Injectable Solution


ondansetron (as ondansetron HCl ) 2 MG/ML Injectable Solution


brompheniramine maleate 0.2 MG/ML / pseudoephedrine hydrochloride 3 MG/ML Oral Solution

brompheniramine maleate 1 MG / pseudoephedrine HCl 15 MG in 5 mL Oral Solution

brompheniramine maleate 1 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Solution


brompheniramine maleate 1 MG / dextromethorphan hydrobromide 5 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Solution

brompheniramine maleate 1 MG / dextromethorphan HBr 5 MG / pseudoephedrine HCl 15 MG in 5 mL Oral Solution

brompheniramine maleate 0.2 MG/ML / dextromethorphan hydrobromide 1 MG/ML / pseudoephedrine hydrochloride 3 MG/ML Oral Solution


sodium chloride 2.16 % Nasal Solution
NaCl 21.6 MG/ML Nasal Solution

sodium chloride 21.6 MG/ML Nasal Solution


iron (as iron sucrose) 100 MG in 5 ML Injection

iron (as iron sucrose) 100 MG per 5 ML Injection

ferric oxide, saccharated 100 MG per 5 ML Injection


gabapentin 300 MG per 6 ML Oral Solution

gabapentin 250 MG per 5 ML Oral Solution


naphazoline HCl 0.05 % / phenylephrine HCl 0.5 % / pyrilamine maleate 0.2 % Nasal Spray

naphazoline hydrochloride 0.5 MG/ML / phenylephrine hydrochloride 5 MG/ML / pyrilamine maleate 2 MG/ML Nasal Spray


APAP 250 MG / doxylamine succinate 25 MG / salicylamide 150 MG Oral Tablet

acetaminophen 250 MG / doxylamine succinate 25 MG / salicylamide 150 MG Oral Tablet


oxacarbazepine 300 MG in 5 mL Oral Suspension

oxacarbazepine 300 MG per 5 ML Oral Suspension


The magnesium salt of esomeprazole, the S-isomer of omeprazole, with gastric proton pump inhibitor activity. In the acidic compartment of parietal cells, esomeprazole is protonated and converted into the active achiral sulphenamide; the active sulphenamide forms one or more covalent disulfide bonds with the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase), thereby inhibiting its activity and the parietal cell secretion of H+ ions into the gastric lumen, the final step in gastric acid production. H+/K+ ATPase is an integral membrane protein of the gastric parietal cell.


A substance derived from any of several Old World coarse prickly-leaved shrubs and subshrubs including the plant Silybum marianum. Milk thistle's active chemical component is silymarin, which is a combination of flavonoids such as silibinin, dehydrosilibinin, silychristin and silydianin. These compounds are antioxidants and may alter the membrane structure of the liver cell, thereby blocking the absorption of toxins; they may also stimulate the production of new liver cells. In addition, milk thistle may increase cellular adenosine triphosphate (ATP) levels, exhibiting dose-dependent cardiac myocyte cytoprotection against doxorubicin. The silibinin component of milk thistle has been shown to inhibit growth factor receptor-mediated mitogenic and cell survival signaling, thereby inhibiting tumor growth. (NCI04)


NaHCO3 520 MG Oral Tablet
sodium bicarbonate 520 MG Oral Tablet


bacitracin zinc 400 UNT in 1 GM / neomycin sulfate 3.5 MG in 1 GM / polymixin B sulfate 5000 UNT in 1 GM Topical Cream

bacitracin zinc 400 UNT in 1 GM / neomycin sulfate 3.5 mg in 1 GM / polymixin B sulfate 5000 UNT in 1 GM Topical Cream

bacitracin 400 UNT/ML / neomycin 3.5 MG/ML / polymyxin B 5000 UNT/ML Topical Cream


calcium carbonate 800 MG / famotidine 10 MG / milk of magnesia 165 MG Chewable Tablet

famotidine 10 MG / calcium carbonate 800 MG / magnesium hydroxide 165 MG Chewable Tablet

calcium carbonate 800 MG / famotidine 10 MG / magnesium hydroxide 165 MG Chewable Tablet


Lactobacillus acidophilus 100 Million UNT Oral Capsule

Lactobacillus acidophilus 1 MG Oral Capsule

Lactobacillus acidophilus 100000000 UNT Oral Capsule


pantoprazole (as sodium) 40 MG Injection


ketorolac tromethamine 15 MG per 1 ML Injection

1 ML ketorolac tromethamine 15 MG/ML Injection

ketorolac tromethamine 15 MG in 1 ML Injection


citalopram 10 MG (as citalopram HBr 12.49 MG) Oral Tablet


menthol 1.25 % / methyl salicylate 30 % / methylnicotinate 0.25 % Topical Gel

menthol 0.0125 MG/MG / methyl salicylate 0.3 MG/MG / methylnicotinate 0.0025 MG/MG Topical Gel


zinc pyrithione 0.02 MG/MG Medicated Bar Soap


NaCl 11.1 MG/ML Nasal Spray
sodium chloride 1.11 % Nasal Spray


calcium 144 MG / magnesium oxide 140 MG / gelatin 324 MG Oral Capsule, as calcium carbonate

calcium carbonate 144 MG / gelatin 324 MG / magnesium oxide 140 MG Oral Capsule


The S-isomer of omeprazole, with gastric proton pump inhibitor activity. In the acidic compartment of parietal cells, esomeprazole is protonated and converted into the active achiral sulfenamide; the active sulfenamide forms one or more covalent disulfide bonds with the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase), thereby inhibiting its activity and the parietal cell secretion of H+ ions into the gastric lumen, the final step in gastric acid production. H+/K+ ATPase is an integral membrane protein of the gastric parietal cell.


A fluorinated hydrocarbon and gaseous substance used as an imaging contrast agent. After administration in microsphere form, perflutren exhibits lower acoustic impedance than blood and improves ultrasound signaling.


The malate salt of almotriptan, a sulfonamide triptan with vasoconstrictor activity. Almotriptan selectively binds to and activates serotonin 5-HT 1B and 1D receptors in the central nervous system (CNS), thereby causing cerebral blood vessel constriction. This may lead to pain relief from vascular headaches. Almotriptan may also relieve vascular headaches by preventing the release of vasoactive neuropeptides from perivascular trigeminal axons in the dura mater during a migraine, by reducing extravasation of plasma proteins, and by decreasing the release of other mediators of inflammation from the trigeminal nerve.


A synthetic lipophilic isopropyl ester prodrug of the active compound travoprost free acid, a prostaglandin F2alpha analog with anti-glaucoma property. Upon administration, travoprost is hydrolysed to a free acid by corneal esterases, and then selectively stimulating the prostaglandin F (FP prostanoid) receptor, thereby increasing the uveoscleral outflow which leads to a reduction in intra-ocular pressure.


A synthetic prostamide and structural prostaglandin analogue with ocular hypotensive activity. Bimatoprost mimics the effects of the endogenous prostamides and reduces intraocular pressure by increasing outflow of aqueous humor through both the pressure-sensitive outflow pathway (the trabecular meshwork), and the pressure-insensitive outflow pathway (the uveoscleral routes). It is not clear whether bimatoprost lowers intraocular pressure by stimulating F-Prostanoid receptors or by acting on specific prostamide receptors.


A hydrochloride salt form of valganciclovir, a prodrug form of ganciclovir, a nucleoside analog of 2'-deoxyguanosine, with antiviral activity. After phosphorylation, valganciclovir is incorporated into DNA, resulting in inhibition of viral DNA polymerase, and viral replication.


Dietary fiber source, extracted from rind of citrus fruits, and used as a gelling agent.


A recombinant urate oxidase enzyme isolated from a genetically-modified strain of Saccharomyces cerevisiae. Urate oxidase catalyzes the oxidation of uric acid to the excretable metabolite allantoin, a molecule that is 5-10 times more water-soluble than uric acid. An enzyme that occurs endogenously in most mammals, urate oxidase is not found in humans. (NCI04)


A recombinant protein which stimulates ERYTHROPOIESIS used to treat ANEMIA.


Crotalidae immune F(ab')2 (equine) 120 MG Injection


rOPINIRole 3 MG (as rOPINIRole hydrochloride) Oral Tablet

ropinirole 3 MG (as ropinirole hydrochloride) Oral Tablet


chondroitin sulfates 400 MG / glucosamine sulfate 500 MG / vitamin C 20 MG Oral Tablet

glucosamine sulfate 500 MG / chondroitin sulfate A 400 MG / ascorbic acid 20 MG Oral Tablet

vitamin C 20 MG / Chondroitin Sulfates 400 MG / Glucosamine Sulfate 500 MG Oral Tablet

vit-C 20 MG / Chondroitin Sulfates 400 MG / Glucosamine Sulfate 500 MG Oral Tablet

ascorbic acid 20 MG / chondroitin sulfates 400 MG / glucosamine sulfate 500 MG Oral Tablet


ibuprofen 100 MG / pseudoephedrine HCl 15 MG in 5 mL Oral Suspension

ibuprofen 100 MG / pseudoephedrine hydrochloride 15 MG per 5 ML Oral Suspension

ibuprofen 20 MG/ML / pseudoephedrine hydrochloride 3 MG/ML Oral Suspension


acetaminophen 325 MG / HYDROcodone bitartrate 7.5 MG Oral Tablet

APAP 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet

APAP 325 MG / HYDROcodone bitartrate 7.5 MG Oral Tablet

HYDROcodone bitartrate 7.5 MG / acetaminophen 325 MG Oral Tablet

acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet


travoprost 40 MCG/ML Ophthalmic Solution

travoprost 0.04 MG/ML Ophthalmic Solution


iron (as ferrous fumarate) 150 MG Oral Tablet


somatropin 8.8 MG/ML Injectable Solution


alemtuzumab 30 MG per 1 ML Injection
1 ML alemtuzumab 30 MG/ML Injection


Magnesium Aspartate 250 MG / K+ Aspartate 250 MG Oral Capsule

Magnesium Aspartate 250 MG / Pot Aspartate 250 MG Oral Capsule

magnesium aspartate 250 MG / potassium aspartate 250 MG Oral Capsule


APAP 500 MG / phenyltoloxamine citrate 60 MG Oral Tablet

acetaminophen 500 MG / phenyltoloxamine citrate 60 MG Oral Tablet


acetaminophen 325 MG / HYDROcodone bitartrate 5 MG Oral Tablet

HYDROcodone bitartrate 5 MG / acetaminophen 325 MG Oral Tablet

acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet

APAP 325 MG / HYDROcodone bitartrate 5 MG Oral Tablet

APAP 325 MG / hydrocodone bitartrate 5 MG Oral Tablet


aminolevulinic acid HCl 20 % Topical Solution

aminolevulinate 200 MG/ML Topical Solution


follitropin alfa 37.5 UNT/ML Injectable Solution


interferon alfa-2a 18,000,000 UNT/mL Injectable Solution

interferon alfa-2a 18,000,000 UNT/ML Injectable Solution

interferon alfa-2a 18000000 UNT/ML Injectable Solution


amylase 60,000 UNT / lipase 16,000 UNT / protease 60,000 UNT Oral Tablet

amylases 60,000 UNT / endopeptidases 60,000 UNT / lipase 16,000 UNT Oral Tablet

amylase 60000 UNT / lipase 16000 UNT / protease 60000 UNT Oral Tablet

lipase 16,000 UNT / amylase 60,000 UNT / protease 60,000 UNT Oral Tablet


guaifenesin 200 MG / hydrocodone bitartrate 2.5 MG per 5 ML Oral Solution

guaiFENesin 40 MG/ML / HYDROcodone bitartrate 0.5 MG/ML Oral Solution

HYDROcodone bitartrate 2.5 MG / guaiFENesin 200 MG in 5 mL Oral Solution

guaiFENesin 200 MG / HYDROcodone bitartrate 2.5 MG per 5 ML Oral Solution

guaifenesin 40 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution


didanosine 125 MG Delayed Release Oral Capsule

dideoxyinosine 125 MG Delayed Release Oral Capsule


didanosine 250 MG Delayed Release Oral Capsule

dideoxyinosine 250 MG Delayed Release Oral Capsule


dideoxyinosine 200 MG Delayed Release Oral Capsule

didanosine 200 MG Delayed Release Oral Capsule


fluorouracil 0.5 % Topical Cream
fluorouracil 5 MG/ML Topical Cream
5-FU 5 MG/ML Topical Cream


ZOLMitriptan 2.5 MG Disintegrating Oral Tablet

zolmitriptan 2.5 MG Disintegrating Oral Tablet


ferrous fumarate (as iron) 106 MG Oral Tablet

ferrous fumarate 324 MG (iron 106 MG) Oral Tablet


drospirenone 3 MG / ethinyl estradiol 0.03 MG Oral Tablet


clindamycin HCl 300 MG Oral Capsule
clindamycin 300 MG Oral Capsule

clindamycin (as clindamycin HCl) 300 MG Oral Capsule


Unithroid 0.025 MG Oral Tablet
UNITHROID 25 MCG Oral Tablet
Unithroid 25 MCG Oral Tablet

levothyroxine sodium 0.025 MG Oral Tablet [Unithroid]


levothyroxine sodium 0.075 MG Oral Tablet [Unithroid]


levothyroxine sodium 0.088 MG Oral Tablet [Unithroid]


UNITHROID 100 MCG Oral Tablet
Unithroid 100 MCG Oral Tablet
Unithroid 0.1 MG Oral Tablet

levothyroxine sodium 0.1 MG Oral Tablet [Unithroid]


Unithroid 0.112 MG Oral Tablet
UNITHROID 112 MCG Oral Tablet
Unithroid 112 MCG Oral Tablet

levothyroxine sodium 0.112 MG Oral Tablet [Unithroid]


levothyroxine sodium 0.125 MG Oral Tablet [Unithroid]


levothyroxine sodium 0.15 MG Oral Tablet [Unithroid]


levothyroxine sodium 0.2 MG Oral Tablet [Unithroid]


Unithroid 300 MCG Oral Tablet
Unithroid 0.3 MG Oral Tablet
UNITHROID 300 MCG Oral Tablet

levothyroxine sodium 0.3 MG Oral Tablet [Unithroid]


meclizine hydrochloride 25 MG Oral Tablet [Travel-Ease]


prochlorperazine 25 MG Rectal Suppository [Compro]


propafenone hydrochloride 150 MG Oral Tablet


propafenone hydrochloride 225 MG Oral Tablet


24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule

dilTIAZem HCl 120 MG 24 HR Extended Release Oral Capsule

24 HR dilTIAZem hydrochloride 120 MG Extended Release Oral Capsule

diltiazem HCl 120 MG 24 HR Extended Release Oral Capsule

dilTIAZem HCl 120 MG 24HR Extended Release Oral Capsule


Capex 0.01 % Medicated Shampoo
Capex 0.1 MG/ML Medicated Shampoo

fluocinolone acetonide 0.1 MG/ML Medicated Shampoo [Capex]


The Magic Bullet 10 MG Rectal Suppository

bisacodyl 10 MG Rectal Suppository [The Magic Bullet]


zinc pyrithione 10 MG/ML Medicated Shampoo [Theraplex Z]


Zostrix Sports 0.7 MG/ML Topical Cream
ZOSTRIX Sports 0.7 MG/ML Topical Cream

capsaicin 0.7 MG/ML Topical Cream [Zostrix Sports]


Tera Gel 5 MG/ML Medicated Shampoo
Tera Gel 0.5 % Medicated Shampoo

coal tar 5 MG/ML Medicated Shampoo [Tera Gel]


calcium polycarbophil 625 MG Oral Tablet [Fiber Tab]


coal tar 20 MG/ML Medicated Shampoo [Theraplex T]


24 HR Naprelan 375 MG Extended Release Oral Tablet

NAPRELAN 375 MG 24HR Extended Release Oral Tablet

Naprelan 375 MG (naproxen sodium 413 MG) 24 HR Extended Release Oral Tablet

24 HR naproxen 375 MG Extended Release Oral Tablet [Naprelan]


ASA 81 MG Delayed Release Oral Tablet [St. Joseph Aspirin]

St. Joseph Aspirin 81 MG Delayed Release Oral Tablet

aspirin 81 MG Delayed Release Oral Tablet [St. Joseph Aspirin]


Monurol 3 GM (as fosfomycin tromethamine) Powder for Oral Solution

fosfomycin 3000 MG Powder for Oral Solution [Monurol]


Hemril-30, 30 MG Rectal Suppository
Hemril 30 MG Rectal Suppository

hydrocortisone acetate 30 MG Rectal Suppository [Hemril]


Synvisc 16 MG per 2 ML Prefilled Syringe

2 ML hylan G-F 20 8 MG/ML Prefilled Syringe [Synvisc]


Mi-Acid Double Strength (calcium carbonate 700 MG / magnesium hydroxide 300 MG) Chewable Tablet

Mi-Acid (calcium carbonate 700 MG / magnesium hydroxide 300 MG) Chewable Tablet

Mi-Acid Double Strength 700 MG (Ca 280 MG) / 300 MG (Mg 125 MG) Chewable Tablet

calcium carbonate 700 MG / magnesium hydroxide 300 MG Chewable Tablet [Mi-Acid Double Strength]


mineral oil, light 1000 MG/ML Oral Solution


Verelan PM 200 MG 24HR Extended Release Oral Capsule

Verelan PM 200 MG 24 HR Extended Release Oral Capsule

24 HR Verelan 200 MG Extended Release Oral Capsule

24 HR verapamil hydrochloride 200 MG Extended Release Oral Capsule [Verelan]


Omni Gel 0.4 % Oral Gel
Omni Just For Kids 0.4 % Oral Gel
Omni Gel 0.004 MG/MG Oral Gel

stannous fluoride 0.004 MG/MG Oral Gel [Omni Gel]


Vivelle 0.025 MG/24HR Twice Weekly Transdermal Patch

84 HR Vivelle 0.00104 MG/HR Transdermal System

Vivelle dot 0.025 MG/Day Twice Weekly Transdermal System

84 HR estradiol 0.00104 MG/HR Transdermal System [Vivelle]


Zaditor 0.025 % (ketotifen fumarate 0.035 % ) Ophthalmic Solution

ketotifen 0.25 MG/ML Ophthalmic Solution [Zaditor]


Cleocin (as clindamycin phosphate) 100 MG Vaginal Insert

clindamycin 100 MG Vaginal Insert [Cleocin]


levETIRAcetam 750 MG Oral Tablet [Keppra]

levetiracetam 750 MG Oral Tablet [Keppra]


Zoloft 20 MG in 1 mL Concentrate for Oral Solution

Zoloft (as sertraline hydrochloride) 20 MG per 1 ML Concentrate for Oral Solution

Zoloft 20 MG per 1 ML Concentrate for Oral Solution

sertraline 20 MG/ML Oral Solution [Zoloft]


2 ML Precedex 0.1 MG/ML Injection
Precedex 200 MCG per 2 ML Injection
Precedex 200 MCG in 2 ML Injection

2 ML dexmedetomidine 0.1 MG/ML Injection [Precedex]


Protonix 40 MG (pantoprazole sodium sesquihydrate 45.1 MG) Delayed Release Oral Tablet

Protonix 40 MG Delayed Release Oral Tablet

pantoprazole 40 MG Delayed Release Oral Tablet [Protonix]


fexofenadine hydrochloride 180 MG Oral Tablet [Allegra]


Tikosyn 0.125 MG Oral Capsule
Tikosyn 125 MCG Oral Capsule

dofetilide 0.125 MG Oral Capsule [Tikosyn]


Tikosyn 250 MCG Oral Capsule
Tikosyn 0.25 MG Oral Capsule

dofetilide 0.25 MG Oral Capsule [Tikosyn]


zonisamide 100 MG Oral Capsule [Zonegran]


OLANZapine 10 MG Disintegrating Oral Tablet [ZyPREXA]

ZyPREXA Zydis 10 MG Disintegrating Oral Tablet

ZyPREXA ZYDIS 10 MG Disintegrating Oral Tablet

Zyprexa Zydis 10 MG Disintegrating Oral Tablet

olanzapine 10 MG Disintegrating Oral Tablet [Zyprexa]


olanzapine 5 MG Disintegrating Oral Tablet [Zyprexa]

OLANZapine 5 MG Disintegrating Oral Tablet [ZyPREXA]

ZyPREXA Zydis 5 MG Disintegrating Oral Tablet

ZyPREXA ZYDIS 5 MG Disintegrating Oral Tablet

Zyprexa Zydis 5 MG Disintegrating Oral Tablet


doxercalciferol 0.002 MG/ML Injectable Solution [Hectorol]

Hectorol 0.002 MG/ML Injectable Solution


Olux 0.05 % Topical Foam
OLUX 0.5 MG/ML Topical Foam

clobetasol propionate 0.5 MG/ML Topical Foam [Olux]


1.7 ML articaine hydrochloride 40 MG/ML / EPINEPHrine 0.01 MG/ML Cartridge [Septocaine]

Septocaine 4 % / 1:100,000 in 1.7 mL Dental Cartridge

1.7 ML articaine hydrochloride 40 MG/ML / epinephrine 0.01 MG/ML Cartridge [Septocaine]


formoterol fumarate 0.012 MG Inhalation Powder [Foradil]


GONAL-f RFF 75 UNT Injection
Gonal F 75 UNT Injection

follitropin alfa 75 UNT Injection [Gonal F]


Differin 1 MG/ML Topical Cream
Differin 0.1 % Topical Cream

adapalene 1 MG/ML Topical Cream [Differin]


colesevelam hydrochloride 625 MG Oral Tablet [Welchol]


TNKase 50 MG Injection
tenecteplase 50 MG Injection [Tnkase]


deferoxamine mesylate 500 MG Injection [Desferal]


10 ML Busulfex 6 MG/ML Injection
Busulfex 60 MG in 10 ML Injection
Busulfex 60 MG per 10 ML Injection

10 ML busulfan 6 MG/ML Injection [Busulfex]


COLAZAL 750 MG Oral Capsule
Colazal 750 MG Oral Capsule

balsalazide disodium 750 MG Oral Capsule [Colazal]


CONCERTA 18 MG 24HR Extended Release Oral Tablet

Concerta 18 MG 24 HR Extended Release Oral Tablet

24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet [Concerta]

24 HR Concerta 18 MG Extended Release Oral Tablet


Vaniqa 139 MG/ML Topical Cream
Vaniqa 13.9 % Topical Cream

eflornithine 139 MG/ML Topical Cream [Vaniqa]


Glucovance 1.25 MG/250 MG (glyburide / metformin HCl) Oral Tablet

Glucovance 1.25 MG/250 MG (glyBURIDE / metFORMIN HCl) Oral Tablet

glyBURIDE 1.25 MG / metFORMIN hydrochloride 250 MG Oral Tablet [Glucovance]

glyburide 1.25 MG / metformin hydrochloride 250 MG Oral Tablet [Glucovance]


glyBURIDE 2.5 MG / metFORMIN hydrochloride 500 MG Oral Tablet [Glucovance]

Glucovance 2.5 MG/500 MG (glyburide / metformin HCl) Oral Tablet

Glucovance 2.5 MG/500 MG (glyBURIDE / metFORMIN HCl) Oral Tablet

glyburide 2.5 MG / metformin hydrochloride 500 MG Oral Tablet [Glucovance]


Glucovance 5 MG/500 MG (glyburide / metformin HCl) Oral Tablet

glyBURIDE 5 MG / metFORMIN hydrochloride 500 MG Oral Tablet [Glucovance]

Glucovance 5 MG/500 MG (glyBURIDE / metFORMIN HCl) Oral Tablet

glyburide 5 MG / metformin hydrochloride 500 MG Oral Tablet [Glucovance]


Pulmicort Respules 0.5 MG per 2 ML Inhalation Suspension

budesonide 0.25 MG/ML Inhalation Suspension [Pulmicort]

Pulmicort Respules 0.25 MG/ML Inhalation Suspension

Pulmicort Respules 0.5 MG in 2 ML Inhalation Suspension


docosanol 100 MG/ML Topical Cream [Abreva]


cetrorelix 0.25 MG Injection [Cetrotide]


Malarone 250/100 (atovaquone / proguanil HCl) Oral Tablet

atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet [Malarone]


MALARONE Pediatric 62.5 MG / 25 MG Oral Tablet

Malarone 62.5/25 (atovaquone / proguanil HCl) Oral Tablet

atovaquone 62.5 MG / proguanil hydrochloride 25 MG Oral Tablet [Malarone]


calcium 500 MG / vitamin D3 100 UNT / vitamin K 40 MCG Chewable Tablet, as calcium carbonate

calcium carbonate 1250 MG / cholecalciferol 100 UNT / vitamin K 0.04 MG Chewable Tablet


Eescula 1.5 MG/ML Ophthalmic Solution
Rescula 0.15 % Ophthalmic Solution

isopropyl unoprostone 1.5 MG/ML Ophthalmic Solution [Eescula]


ENTsol 3 % Nasal Spray
ENTsol 30 MG/ML Nasal Spray
NaCl 30 MG/ML Nasal Spray [ENTsol]
ENTSOL 3 % Nasal Spray

sodium chloride 30 MG/ML Nasal Spray [ENTsol]


candesartan cilexetil 16 MG / HCTZ 12.5 MG Oral Tablet [Atacand HCT]

candesartan cilexetil 16 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet [Atacand HCT]

candesartan cilexetil 16 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Atacand HCT]


candesartan cilexetil 32 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet [Atacand HCT]

candesartan cilexetil 32 MG / HCTZ 12.5 MG Oral Tablet [Atacand HCT]

candesartan cilexetil 32 MG / hydrochlorothiazide 12.5 MG Oral Tablet [Atacand HCT]


Urso-250 250 MG Oral Tablet
Urso-250 Oral Tablet
Urso 250 MG Oral Tablet


SUMAtriptan 100 MG Oral Tablet [Imitrex]

sumatriptan 100 MG Oral Tablet [Imitrex]

Imitrex 100 MG (sumatriptan succinate 140 MG) Oral Tablet

Imitrex 100 MG (SUMAtriptan succinate 140 MG) Oral Tablet


sevelamer hydrochloride 800 MG Oral Tablet [RenaGel]


Glucophage XR 500 MG 24HR Extended Release Oral Tablet

Glucophage XR 24 HR 500 MG Extended Release Oral Tablet

24 HR metFORMIN hydrochloride 500 MG Extended Release Oral Tablet [Glucophage]

24 HR Glucophage 500 MG Extended Release Oral Tablet

24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet [Glucophage]


oxyCODONE hydrochloride 30 MG Oral Tablet [Roxicodone]

oxycodone hydrochloride 30 MG Oral Tablet [Roxicodone]


eptacog alfa activated 0.001 MG Injection [Novoseven]


Colocort 1.67 MG/ML Enema
Colocort 100 MG per 60 ML Enema
COLOCORT 100 MG per 60 mL Enema

hydrocortisone 1.67 MG/ML Enema [Colocort]


Kaletra 80 MG / 20 MG in 1 mL Oral Solution

Kaletra 80 MG / 20 MG per 1 ML Oral Solution

lopinavir 80 MG/ML / ritonavir 20 MG/ML Oral Solution [Kaletra]


miFEPRIStone 200 MG Oral Tablet [Mifeprex]

mifepristone 200 MG Oral Tablet [Mifeprex]


Lescol XL 80 MG 24HR Extended Release Oral Tablet

Lescol XL 80 MG 24 HR Extended Release Oral Tablet

24 HR Lescol XL (as fluvastatin sodium) 80 MG Extended Release Oral Tablet

24 HR fluvastatin 80 MG Extended Release Oral Tablet [Lescol]


levofloxacin 750 MG Oral Tablet [Levaquin]

levoFLOXacin 750 MG Oral Tablet [Levaquin]


FLURA-DROPS 1 MG in 0.2 mL Oral Solution

Flura-Drops 11 MG (fluoride ion 5 MG) per 1 ML Oral Solution

Flura-Drops 0.55 MG (fluoride ion 0.25 MG) per Drop Oral Solution

sodium fluoride 11 MG/ML Oral Solution [Flura-Drops]


Fosamax 70 MG (as alendronate sodium 91.4 MG) Oral Tablet

alendronic acid 70 MG Oral Tablet [Fosamax]


TAZORAC 0.05 % Topical Cream
Tazorac 0.5 MG/ML Topical Cream
Tazorac 0.05 % Topical Cream

tazarotene 0.5 MG/ML Topical Cream [Tazorac]


Tazorac 0.1 % Topical Cream
Tazorac 1 MG/ML Topical Cream
TAZORAC 0.1 % Topical Cream

tazarotene 1 MG/ML Topical Cream [Tazorac]


ddI 125 MG Delayed Release Oral Capsule [Videx]

Videx 125 MG Delayed Release Oral Capsule

Videx EC 125 MG Delayed Release Oral Capsule

dideoxyinosine 125 MG Delayed Release Oral Capsule [Videx]

didanosine 125 MG Delayed Release Oral Capsule [Videx]


Videx EC 200 MG Delayed Release Oral Capsule

dideoxyinosine 200 MG Delayed Release Oral Capsule [Videx EC]

ddI 200 MG Delayed Release Oral Capsule [Videx EC]

didanosine 200 MG Delayed Release Oral Capsule [Videx EC]


dideoxyinosine 400 MG Delayed Release Oral Capsule [Videx EC]

Videx EC 400 MG Delayed Release Oral Capsule

ddI 400 MG Delayed Release Oral Capsule [Videx EC]

didanosine 400 MG Delayed Release Oral Capsule [Videx EC]


Venofer (iron) 50 MG in 2.5 mL Injection

2.5 ML iron sucrose 20 MG/ML Injection [Venofer]


Micardis-HCT 40/12.5 (telmisartan / hydrochlorothiazide) Oral Tablet

hydroCHLOROthiazide 12.5 MG / telmisartan 40 MG Oral Tablet [Micardis-HCT]

Micardis-HCT 40/12.5 (telmisartan / hydroCHLOROthiazide) Oral Tablet

HCTZ 12.5 MG / telmisartan 40 MG Oral Tablet [Micardis-HCT]

hydrochlorothiazide 12.5 MG / telmisartan 40 MG Oral Tablet [Micardis-HCT]


hydroCHLOROthiazide 12.5 MG / telmisartan 80 MG Oral Tablet [Micardis-HCT]

Micardis-HCT 80/12.5 (telmisartan / hydroCHLOROthiazide) Oral Tablet

Micardis-HCT 80 MG / 12.5 MG Oral Tablet

HCTZ 12.5 MG / telmisartan 80 MG Oral Tablet [Micardis-HCT]

Micardis-HCT 80/12.5 (telmisartan / hydrochlorothiazide) Oral Tablet

hydrochlorothiazide 12.5 MG / telmisartan 80 MG Oral Tablet [Micardis-HCT]


Seroquel 300 MG (as quetiapine fumarate) Oral Tablet

QUEtiapine 300 MG Oral Tablet [SEROquel]

SEROquel 300 MG (as QUEtiapine fumarate) Oral Tablet

quetiapine 300 MG Oral Tablet [Seroquel]


Norditropin 15 MG in 1.5 ML Pen Injector

Norditropin 15 MG per 1.5 ML Pen Injector

1.5 ML somatropin 10 MG/ML Pen Injector [Norditropin]


1 ML Cellugel 20 MG/ML Prefilled Syringe

1 ML hypromellose 20 MG/ML Prefilled Syringe [Cellugel]


OLANZapine 20 MG Oral Tablet [ZyPREXA]
olanzapine 20 MG Oral Tablet [Zyprexa]
Zyprexa 20 MG Oral Tablet


prednisoLONE 3 MG/ML Oral Solution [Orapred]

prednisolone 3 MG/ML Oral Solution [Orapred]


Concerta 54 MG 24 HR Extended Release Oral Tablet

CONCERTA 54 MG 24HR Extended Release Oral Tablet

24 HR Concerta 54 MG Extended Release Oral Tablet

24 HR methylphenidate hydrochloride 54 MG Extended Release Oral Tablet [Concerta]


Protopic 0.1 % Topical Ointment
Protopic 0.001 MG/MG Topical Ointment

tacrolimus 0.001 MG/MG Topical Ointment [Protopic]


Protopic 0.03 % Topical Ointment
Protopic 0.0003 MG/MG Topical Ointment

tacrolimus 0.0003 MG/MG Topical Ointment [Protopic]


MYOBLOC 10,000 UNT in 2 ML Injection
Myobloc 10000 UNT per 2 ML Injection

2 ML rimabotulinumtoxinB 5000 UNT/ML Injection [Myobloc]


Detrol LA 2 MG 24HR Extended Release Oral Capsule

24 HR Detrol 2 MG Extended Release Oral Capsule

Detrol LA 2 MG 24 HR Extended Release Oral Capsule

24 HR tolterodine tartrate 2 MG Extended Release Oral Capsule [Detrol]


Norco 5/325 (HYDROcodone bitartrate / APAP) Oral Tablet

Norco 5/325 (hydrocodone bitartrate / APAP) Oral Tablet

APAP 325 MG / HYDROcodone Bitartrate 5 MG Oral Tablet [Norco]

acetaminophen 325 MG / HYDROcodone bitartrate 5 MG Oral Tablet [Norco]

APAP 325 MG / Hydrocodone Bitartrate 5 MG Oral Tablet [Norco]

acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet [Norco]


APAP 325 MG / Hydrocodone Bitartrate 7.5 MG Oral Tablet [Norco]

Norco 7.5/325 (HYDROcodone / acetaminophen) Oral Tablet

Norco 7.5/325 (hydrocodone / acetaminophen) Oral Tablet

acetaminophen 325 MG / HYDROcodone bitartrate 7.5 MG Oral Tablet [Norco]

APAP 325 MG / HYDROcodone Bitartrate 7.5 MG Oral Tablet [Norco]

acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG Oral Tablet [Norco]


24 HR Detrol LA 4 MG Extended Release Oral Capsule

Detrol LA 4 MG 24 HR Extended Release Oral Capsule

Detrol LA 4 MG 24HR Extended Release Oral Capsule

24 HR tolterodine tartrate 4 MG Extended Release Oral Capsule [Detrol]


STARLiX 60 MG Oral Tablet
Starlix 60 MG Oral Tablet


STARLiX 120 MG Oral Tablet
Starlix 120 MG Oral Tablet

nateglinide 120 MG Oral Tablet [Starlix]


telmisartan 20 MG Oral Tablet [Micardis]


amiodarone hydrochloride 400 MG Oral Tablet [Pacerone]


Angiomax 250 MG Injection
Angiomax 50 MG/ML Injection
Angiomax 250 MG per 5 ML Injection


Remeron 15 MG Disintegrating Oral Tablet

Remeron SolTab 15 MG Disintegrating Oral Tablet

mirtazapine 15 MG Disintegrating Oral Tablet [Remeron]


Remeron 30 MG Disintegrating Oral Tablet

Remeron SolTab 30 MG Disintegrating Oral Tablet

mirtazapine 30 MG Disintegrating Oral Tablet [Remeron]


5-5-fluorouracil 5 MG/ML Topical Cream [Carac]


peginterferon alfa-2b 0.05 MG Injection [Pegintron]


peginterferon alfa-2b 0.08 MG Injection [Pegintron]


peginterferon alfa-2b 0.12 MG Injection [Pegintron]


Pegintron 0.15 MG Injection
PegIntron 150 MCG Injection
Pegintron 150 MCG Injection

peginterferon alfa-2b 0.15 MG Injection [Pegintron]


Benzaclin (benzoyl peroxide 5 % / clindamycin 1 % (as clindamycin phosphate 1.2 % ) ) Topical Gel

Benzaclin (benzoyl peroxide 5 % / clindamycin 1 % ) Topical Gel

benzoyl peroxide 0.05 MG/MG / clindamycin 0.01 MG/MG Topical Gel [Benzaclin]


Cancidas 50 MG (equivalent to caspofungin 54.6 MG) Injection

caspofungin acetate 50 MG Injection [Cancidas]


Cancidas 70 MG (equivalent to caspofungin 75.6 MG) Injection

caspofungin acetate 70 MG Injection [Cancidas]


Geodon (as ziprasidone hydrochloride monohydrate) 40 MG Oral Capsule


Geodon (as ziprasidone hydrochloride monohydrate) 60 MG Oral Capsule


Geodon (as ziprasidone hydrochloride monohydrate) 80 MG Oral Capsule


nilutamide 150 MG Oral Tablet [Nilandron]


Toprol XL 25 MG 24 HR Extended Release Oral Tablet

24 HR Toprol XL 25 MG Extended Release Oral Tablet

Toprol XL (metoprolol succinate 25 MG (as metoprolol succinate 23.75 MG equivalent to 25 MG metoprolol tartrate)) 24 HR Extended Release Oral Tablet

Toprol XL 25 MG 24HR Extended Release Oral Tablet

24 HR Toprol 25 MG Extended Release Oral Tablet

24 HR metoprolol succinate 25 MG Extended Release Oral Tablet [Toprol]


Hemocyte 324 MG (iron 106 MG) Oral Tablet

ferrous fumarate 324 MG Oral Tablet [Hemocyte]


MS 30 MG Extended Release Oral Capsule [Kadian]

Kadian 30 MG Extended Release Oral Capsule

morphine sulfate 30 MG Extended Release Oral Capsule [Kadian]


Kadian 60 MG Extended Release Oral Capsule

MS 60 MG Extended Release Oral Capsule [Kadian]

morphine sulfate 60 MG Extended Release Oral Capsule [Kadian]


somatropin 0.2 MG in 0.25 ML Prefilled Syringe

0.25 ML somatropin 0.8 MG/ML Prefilled Syringe

somatropin 0.2 MG per 0.25 ML Prefilled Syringe


somatropin 0.4 MG per 0.25 ML Prefilled Syringe

somatropin 0.4 MG in 0.25 ML Prefilled Syringe

0.25 ML somatropin 1.6 MG/ML Prefilled Syringe


somatropin 0.8 MG per 0.25 ML Prefilled Syringe

somatropin 0.8 MG in 0.25 ML Prefilled Syringe

0.25 ML somatropin 3.2 MG/ML Prefilled Syringe


somatropin 1.2 MG in 0.25 ML Prefilled Syringe

0.25 ML somatropin 4.8 MG/ML Prefilled Syringe

somatropin 1.2 MG per 0.25 ML Prefilled Syringe


somatropin 1.4 MG per 0.25 ML Prefilled Syringe

somatropin 1.4 MG in 0.25 ML Prefilled Syringe

0.25 ML somatropin 5.6 MG/ML Prefilled Syringe


somatropin 1.6 MG per 0.25 ML Prefilled Syringe

0.25 ML somatropin 6.4 MG/ML Prefilled Syringe

somatropin 1.6 MG in 0.25 ML Prefilled Syringe


somatropin 1.8 MG per 0.25 ML Prefilled Syringe

somatropin 1.8 MG in 0.25 ML Prefilled Syringe

0.25 ML somatropin 7.2 MG/ML Prefilled Syringe


Genotropin 2 MG per 0.25 ML Prefilled Syringe

Genotropin 2 MG in 0.25 ML Prefilled Syringe

Genotropin MiniQuick 2 MG per 0.25 ML Prefilled Syringe

0.25 ML somatropin 8 MG/ML Prefilled Syringe [Genotropin]


Iodosorb 0.009 MG/MG Topical Gel
IODOSORB 0.9 % Topical Gel
Iodosorb 0.9 % Topical Gel

cadexomer iodine 0.009 MG/MG Topical Gel [Iodosorb]


Valcyte 450 MG (valGANciclovir hydrochloride 496.3 MG) Oral Tablet

Valcyte 450 MG (valganciclovir hydrochloride 496.3 MG) Oral Tablet

valGANciclovir 450 MG Oral Tablet [Valcyte]

valganciclovir 450 MG Oral Tablet [Valcyte]


Axert 12.5 MG (as almotriptan malate) Oral Tablet


Celexa 10 MG Oral Tablet
citalopram 10 MG Oral Tablet [CeleXA]
CeleXA 10 MG Oral Tablet


methotrexate 10 MG Oral Tablet [Trexall]


methotrexate 7.5 MG Oral Tablet [Trexall]


methotrexate 15 MG Oral Tablet [Trexall]


CroFab (Crotalidae polyvalent immune fab (ovine) equivalent to 1 GM total protein) Injection

Agkistrodon piscivorus antivenin 780 UNT / Crotalus adamanteus antivenin 420 UNT / Crotalus atrox antivenin 1270 UNT / Crotalus scutulatus antivenin 5570 UNT Injection [CroFab]


carbetapentane / guaiFENesin / phenylephrine

carbetapentane / guaifenesin / phenylephrine


carbinoxamine / HYDROcodone / pseudoephedrine

carbinoxamine / hydrocodone / pseudoephedrine


A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.


A fixed combination of two protease inhibitors, lopinavir and ritonavir, used to treat human immunodeficiency virus (HIV) infection. The ritonavir in the combination drug increases the concentration and biological half-life of lopinavir but is not present in sufficient concentration to act as a protease inhibitor.


Name of the FDA approved preparation from J&J.


The mesylate salt of imatinib, a tyrosine kinase inhibitor with antineoplastic activity. Imatinib binds to an intracellular pocket located within tyrosine kinases (TK), thereby inhibiting ATP binding and preventing phosphorylation and the subsequent activation of growth receptors and their downstream signal transduction pathways. This agent inhibits TK encoded by the bcr-abl oncogene as well as receptor TKs encoded by the c-kit and platelet-derived growth factor receptor (PDGFR) oncogenes. Inhibition of the bcr-abl TK results in decreased proliferation and enhanced apoptosis in malignant cells of Philadelphia-positive (Ph+) hematological malignancies such as CML and ALL; effects on c-kit TK activity inhibit mast-cell and cellular proliferation in those diseases overexpressing c-kit, such as mastocytosis and gastrointestinal stromal tumor (GIST).


didanosine 400 MG Delayed Release Oral Capsule

dideoxyinosine 400 MG Delayed Release Oral Capsule


acetaminophen 1000 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG / pseudoephedrine HCl 60 MG in 30 mL Oral Solution

acetaminophen 1000 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG / pseudoephedrine HCl 60 MG per 30 ML Oral Solution

acetominophen 500 MG / dextromethorphan HBr 15 MG / doxylamine succinate 6.25 MG / pseudoephedrine HCl 30 MG per 15 ML Oral Solution

acetaminophen 33.3 MG/ML / dextromethorphan hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML / pseudoephedrine hydrochloride 2 MG/ML Oral Solution

APAP 33.3 MG/ML / Dextromethorphan Hydrobromide 1 MG/ML / doxylamine succinate 0.417 MG/ML / Pseudoephedrine Hydrochloride 2 MG/ML Oral Solution


levothyroxine sodium 0.05 MG Oral Tablet [Unithroid]


levothyroxine sodium 0.175 MG Oral Tablet [Unithroid]


AndroGel 1 % (50MG / 5GM) Transdermal Gel

5000 MG testosterone 0.01 MG/MG Topical Gel [Androgel]


Tikosyn 500 MCG Oral Capsule
Tikosyn 0.5 MG Oral Capsule

dofetilide 0.5 MG Oral Capsule [Tikosyn]


insulin glargine 100 UNT/ML Injectable Solution [Lantus]


Targretin 0.01 MG/MG Topical Gel
Targretin 1 % Topical Gel

bexarotene 0.01 MG/MG Topical Gel [Targretin]


CONCERTA 36 MG 24HR Extended Release Oral Tablet

24 HR Concerta 36 MG Extended Release Oral Tablet

Concerta 36 MG 24 HR Extended Release Oral Tablet

24 HR methylphenidate hydrochloride 36 MG Extended Release Oral Tablet [Concerta]


Depakote ER 500 MG 24HR Extended Release Oral Tablet

24 HR Depakote 500 MG Extended Release Oral Tablet

Depakote 500 MG 24 HR Extended Release Oral Tablet

24 HR divalproex sodium 500 MG Extended Release Oral Tablet [Depakote]


Sulfamylon 5 % Powder for Topical Solution

mafenide 50 MG/ML Topical Solution [Sulfamylon]


oxyCODONE hydrochloride 15 MG Oral Tablet [Roxicodone]

oxycodone hydrochloride 15 MG Oral Tablet [Roxicodone]


Pepcid Complete (calcium carbonate 800 MG / famotidine 10 MG / magnesium hydroxide 165 MG) Chewable Tablet

Pepcid Complete Dual Action 10 MG / 800 MG (Ca 320 MG) / 165 MG Chewable Tablet

calcium carbonate 800 MG / famotidine 10 MG / magnesium hydroxide 165 MG Chewable Tablet [Pepcid Complete]


dideoxyinosine 250 MG Delayed Release Oral Capsule [Videx EC]

ddI 250 MG Delayed Release Oral Capsule [Videx EC]

Videx EC 250 MG Delayed Release Oral Capsule

didanosine 250 MG Delayed Release Oral Capsule [Videx EC]


Trizivir (abacavir 300 MG / lamiVUDine 150 MG / zidovudine 300 MG) Oral Tablet

abacavir 300 MG / lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [Trizivir]

TRIZIVIR 300 MG / 150 MG / 300 MG Oral Tablet

abacavir 300 MG / 3TC 150 MG / AZT 300 MG Oral Tablet [Trizivir]

Trizivir (abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG) Oral Tablet

abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG Oral Tablet [Trizivir]


TRAVATAN Z 0.004 % Ophthalmic Solution
Travatan Z 0.004 % Ophthalmic Solution
Travatan 0.004 % Ophthalmic Solution
Travatan 0.04 MG/ML Ophthalmic Solution

travoprost 0.04 MG/ML Ophthalmic Solution [Travatan]


zolmitriptan 2.5 MG Disintegrating Oral Tablet [Zomig]

ZOLMitriptan 2.5 MG Disintegrating Oral Tablet [Zomig]

Zomig-ZMT 2.5 MG Disintegrating Oral Tablet


somatropin 0.6 MG per 0.25 ML Prefilled Syringe

somatropin 0.6 MG in 0.25 ML Prefilled Syringe

0.25 ML somatropin 2.4 MG/ML Prefilled Syringe


acetaminophen / doxylamine / pseudoephedrine


Folacin 0.8 MG Oral Tablet
folate 0.8 MG Oral Tablet [Folacin]
FOLACIN 800 MCG Oral Tablet


Geodon (as ziprasidone hydrochloride monohydrate) 20 MG Oral Capsule


Lumigan 0.3 MG/ML Ophthalmic Solution
Lumigan 0.03 % Ophthalmic Solution
LUMIGAN 0.03 % Ophthalmic Solution

bimatoprost 0.3 MG/ML Ophthalmic Solution [Lumigan]


Matricaria chamomilla extract
German chamomilla extract
Matricaria recutita extract


Arnica montana extract
mountain arnica extract


An extract of Uncaria tomentosa (U. tomentosa), also called Cat's claw, a native Amazonian plant belonging to the Rubiaceae species, with potential anti-inflammatory, immunomodulating, antioxidant and antineoplastic activities. Although the exact mechanism(s) by which U. tomentosa extract exerts its effect(s) has yet to be fully elucidated, this extract may inhibit the proliferation of certain types of cancer cells. This extract may modulate inflammatory and immune responses through the stimulation of T- and B-lymphocytes and certain cytokines, including interleukin (IL)-1, IL-6 and tumor necrosis factor-alpha (TNF-a). Components in U. tomentosa may both induce repair of chemically-induced DNA damage and scavenge free radicals, which may protect against reactive oxygen species (ROS)-mediated cellular damage. In addition, this extract stimulates myelopoiesis, which may prevent chemotherapy-induced neutropenia.


Lavandula angustifolia subsp. angustifolia flowering top extract


An extract of the rhizome of the perennial plant Zingiber officinale with potential antineoplastic activity. Ginger extract contains a number of different phenolic compounds, some of which have displayed antineoplastic, anti-inflammatory, and antioxidant activities. This agent also exhibits antiemetic properties.


A saturated solution of formaldehyde, water, and typically another agent, most commonly methanol. In its typical form, formalin is 37% formaldehyde by weight (40% by volume), 6-13% methanol, and the rest water.


The hydrobromide salt form of galantamine, a tertiary alkaloid obtained synthetically or naturally from the bulbs and flowers of Narcissus and several other genera of the Amaryllidaceae family with anticholinesterase and neurocognitive-enhancing activities. Galantamine competitively and reversibly inhibits acetylcholinesterase, thereby increasing the concentration and enhancing the action of acetylcholine (Ach). In addition, galantamine is a ligand for nicotinic acetylcholine receptors, which may increase the presynaptic release of Ach and activate postsynaptic receptors. This agent may improve neurocognitive function in mild and moderate Alzheimer' s disease and may reduce abstinence-induced cognitive symptoms that promote smoking relapse.


The sodium salt of methotrexate, an antimetabolite with antineoplastic and immunomodulating properties. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Methotrexate also exhibits potent immunosuppressant properties. (NCI04)


Any of the four forms, alpha, beta, gamma and delta, of a member of the vitamin E family, with potential hypocholesterolemic, antithrombotic, antioxidant, immunomodulating and antineoplastic activities. Tocotrienol inhibits the activity of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, thereby lowering cholesterol levels. In addition, tocotrienol acts through multiple signal transduction pathways to induce cell cycle arrest and caspase-mediated apoptosis, and to decrease tumor cell proliferation. In addition, this agent may inhibit angiogenesis through the blockage of vascular endothelial growth factor receptor (VEGFR) and the subsequent inhibition of tumor cell-induced vessel formation. Also, this agent prevents free radical formation and inhibits lipid peroxidation, thereby preventing DNA cell damage. Tocotrienol farnesyl isoprenoid side chains contain 3 double bonds, which are absent in tocopherols, likely contribute to its anti-cancer activities.


A species of ENTEROVIRUS infecting humans and containing 10 serotypes, mostly coxsackieviruses.


An oral dietary supplement containing a natural cyclic monoterpene, and a major component of the oil extracted from citrus peels, with potential chemopreventive and antineoplastic activities. Upon oral administration, D-limonene activates aldehyde dehydrogenase 3A1 (ALDH3A1), thereby decreasing aldehyde level. This may protect salivary stem/progenitor cells (SSPCs) from toxic aldehydes and prevent or improve radiation-induced xerostomia. Limonene and its metabolites perillic acid, dihydroperillic acid, uroterpenol and limonene 1,2-diol may also inhibit tumor growth through inhibition of p21-dependent signaling and may induce apoptosis via the induction of the transforming growth factor beta-signaling pathway. In addition, they inhibit post-translational modification of signal transduction proteins, resulting in G1 cell cycle arrest as well as differential expression of cell cycle- and apoptosis-related genes.


The hyrochloride salt form of amorolfine, a morpholine antifungal agent. Amorolfine inhibits delta-14-reductase and delta-7,8-isomerase, which depletes ergosterol and causes ignosterol to accumulate in the fungal cytoplasmic cell membrane.


A topical nonsteroidal anti-inflammatory drug that is used in eye drops for the treatment of eye pain and swelling.


A selective aldosterone receptor antagonist. Eplerenone binds to the mineralocorticoid receptor and blocks the binding of aldosterone, thereby decreasing sodium resorption and subsequently increasing water outflow. This leads to a decrease in blood pressure. Eplerenone is used in the treatment of hypertension and congestive heart failure.


A recombinant dimeric fusion protein consisting of the extracellular CD2-binding domain of the human leukocyte function-associated antigen 3 (LFA-3; CD58) linked to the Fc portion of human immunoglobulin G1 (IgG1) with potential immunosuppressive activity. Alefacept binds to the CD2 receptor expressed on the majority of T lymphocytes, blocking the binding of endogenous LFA-3, located on antigen-presenting cells (APCs), to the CD2 receptor; the activation and proliferation of T lymphocytes in response to LFA-3 binding is thus inhibited. In addition, binding of the IgG1 moiety of this agent to the Fc gamma receptor on the surface of natural killer (NK)cells may bridge NK cells and target T lymphocytes, initiating NK cell-mediated apoptosis of T lymphocytes.


A soluble protein immunogen used as a model antigen to study antibody:antigen binding and B- and T-cell responses in the laboratory. (NCI04)


A statin with antilipidemic and potential antineoplastic activities. Rosuvastatin selectively and competitively binds to and inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a precursor of cholesterol. This leads to a decrease in hepatic cholesterol levels and increase in uptake of LDL cholesterol. In addition, rosuvastatin, like other statins, exhibits pro-apoptotic, growth inhibitory, and pro-differentiation activities in a variety of tumor cell types; these antineoplastic activities may be due, in part, to inhibition of the isoprenylation of Ras and Rho GTPases and related signaling cascades.


A synthetic decapeptide and antagonist of naturally occurring gonadotropin-releasing hormone (GnRH). Abarelix directly and competitively binds to and blocks the gonadotropin releasing hormone receptor in the anterior pituitary gland, thereby inhibiting the secretion and release of luteinizing hormone (LH) and follicle stimulating hormone (FSH). In males, the inhibition of LH secretion prevents the release of testosterone. As a result, this may relieve symptoms associated with prostate hypertrophy or prostate cancer, since testosterone is required to sustain prostate growth.


An orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its active metabolite roflumilast N-oxide selectively and competitively bind to and inhibit PDE4, which leads to an increase of both intracellular levels of cyclic-3',5'-adenosine monophosphate (cAMP) and cAMP-mediated signaling. cAMP prevents phosphorylation of spleen tyrosine kinase (SYK) and abrogates activation of the PI3K/AKT/mTOR signaling pathway, which may result in the induction of apoptosis. PDE4, a member of the PDE superfamily that hydrolyses cAMP and 3',5'-cyclic guanosine monophosphate (cGMP) to their inactive 5' monophosphates, is upregulated in a variety of cancers and may contribute to chemoresistance; it also plays a key role in inflammation, especially in inflammatory airway diseases.


A humanized monoclonal antibody directed against the C-epsilon 3 domain of immunoglobulin E. Olizumab binds to this IgE domain, thereby preventing IgE from binding to its high-affinity mast-cell receptor. (NCI04)


antihemophilic factor, human recombinant residues 743-1636 deleted


A humanized immunoglobulin G1 (IgG1) monoclonal antibody directed against interleukin-5 (IL-5) with anti-asthmatic and potential immunosuppressive activity. Upon subcutaneous administration, mepolizumab selectively binds to IL-5, preventing it from associating with interleukin-5 receptor subunit alpha (IL5RA) on the surface of eosinophils and their progenitors. IL-5 plays a role in the regulation of eosinophil development from hematopoietic progenitors as well as eosinophil maturation, differentiation, mobilization, activation, and survival. IL-5 also play a role in the pathogenesis of some phenotypes of hypereosinophilic syndrome (HES).


A long-acting beta-2 adrenergic agonist and isomer of formoterol with bronchodilator activity. Arformoterol selectively binds to and activates beta-2 adrenergic receptors in bronchiolar smooth muscle, thereby causing stimulation of adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cAMP). Increased intracellular cAMP levels cause relaxation of bronchial smooth muscle and lead to a reduced release of inflammatory mediators from mast cells. This may eventually lead to an improvement of airway function.


A natural tocopherol and one of the most potent antioxidant tocopherols. It exhibits antioxidant activity by virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus. It has four methyl groups on the 6-chromanol nucleus. The natural d form of alpha-tocopherol is more active than its synthetic dl-alpha-tocopherol racemic mixture.


A synthetic analog of 2-deoxyguanosine with antiviral activity against hepatitis B virus (HBV). Entecavir is activated in vivo to a 5-triphosphate metabolite. In turn, the triphosphate form competes with the natural substrate deoxyguanosine triphosphate (dGTP) for incorporation into viral DNA. The incorporation of the activated triphosphate metabolite of entecavir inhibits the reverse transcriptase (RT) viral RNA-dependent HBV DNA polymerase and, so, the replication of viral DNA and transcription.


A benzenesulfonamide derivative and phosphodiesterase type 5 (PDE5) inhibitor with vasodilatory activity. Vardenafil selectively inhibits PDE5, thus inhibiting the degradation of cyclic guanosine monophosphate (cGMP) found in the smooth muscle of the corpus cavernosa and corpus spongiosum of the penis. The inhibition of cGMP degradation results in prolonged muscle relaxation, vasodilation, and blood engorgement of the corpus cavernosa, prolonging penile erection.


A synthetic, nonsteroidal anti-inflammatory drug (NSAID) with antipyretic, analgesic, and potential antineoplastic properties. Etoricoxib specifically binds to and inhibits the enzyme cyclooxygenase-2 (COX-2), resulting in inhibition of the conversion of arachidonic acid into prostaglandins. Inhibition of COX-2 may induce apoptosis and inhibit tumor cell proliferation and angiogenesis.


The hydrochloride salt form of vardenafil, a benzenesulfonamide derivative and phosphodiesterase type 5 (PDE5) inhibitor with vasodilatory activity. Vardenafil selectively inhibits PDE5, thus inhibiting the degradation of cyclic guanosine monophosphate (cGMP) found in the smooth muscle of the corpus cavernosa and corpus spongiosum of the penis. The inhibition of cGMP degradation results in prolonged muscle relaxation, vasodilation, and blood engorgement of the corpus cavernosa, thereby prolonging penile erection. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C76318" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C76318" NCI Thesaurus)


A polyatomic ion whose formula is HCO3-.


abacavir 300 MG / 3TC 150 MG / AZT 300 MG Oral Tablet

abacavir 300 MG / lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet

abacavir (as abacavir sulfate) 300 MG / 3TC 150 MG / AZT 300 MG Oral Tablet

abacavir sulfate 300 MG / lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet

abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG Oral Tablet


APAP 125 MG Rectal Suppository
acetaminophen 125 MG Rectal Suppository


APAP 160 MG Oral Capsule
acetaminophen 160 MG Oral Capsule


acetaminophen 160 MG per 5 ML Oral Suspension

acetaminophen 80 MG per 2.5 ML Oral Suspension

acetaminophen 320 MG per 10 ML Oral Suspension

acetaminophen 160 MG in 5 mL Oral Suspension

acetaminophen 650 MG per 20.3 ML Oral Suspension


acetaminophen 325 MG per 10.15 ML Oral Solution

acetaminophen 160 MG in 5 mL Oral Solution

acetaminophen 160 MG per 5 ML Oral Solution

acetaminophen 650 MG per 20.3 ML Oral Solution

acetaminophen 80 MG per 2.5 ML Oral Solution


APAP 325 MG / chlorpheniramine maleate 2 MG Oral Tablet

acetaminophen 325 MG / chlorpheniramine maleate 2 MG Oral Tablet


acetaminophen 325 MG / pseudoephedrine HCl 30 MG Oral Tablet

APAP 325 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet

acetaminophen 325 MG / pseudoephedrine hydrochloride 30 MG Oral Tablet


acetaminophen 500 MG in 15 mL Oral Solution


APAP 500 MG / Caffeine 65 MG Oral Tablet

acetaminophen 500 MG / caffeine 65 MG Oral Tablet


acetaminophen 500 MG / diphenhydramine hydrochloride 25 MG Oral Tablet

acetaminophen 500 MG / diphenhydrAMINE HCl 25 MG Oral Tablet

APAP 500 MG / diphenhydramine hydrochloride 25 MG Oral Tablet

acetaminophen 500 MG / diphenhydrAMINE hydrochloride 25 MG Oral Tablet

APAP 500 MG / diphenhydrAMINE hydrochloride 25 MG Oral Tablet


acetaminophen 500 MG / diphenhydrAMINE citrate 38 MG Oral Tablet

APAP 500 MG / diphenhydrAMINE Citrate 38 MG Oral Tablet

APAP 500 MG / Diphenhydramine Citrate 38 MG Oral Tablet

acetaminophen 500 MG / diphenhydramine citrate 38 MG Oral Tablet


acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet

APAP 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet


APAP 80 MG Oral Capsule
acetaminophen 80 MG Oral Capsule


acetaZOLAMIDE (as acetaZOLAMIDE sodium) 500 MG Injection

acetazolamide (as acetazolamide sodium) 500 MG Injection


acetic acid 2.5 MG/ML Irrigation Solution


acetylcysteine 100 MG/ML Inhalation Solution


acetylcysteine 200 MG/ML Inhalation Solution


acrivastine 8 MG / pseudoephedrine HCl 60 MG Oral Capsule

acrivastine 8 MG / pseudoephedrine hydrochloride 60 MG Oral Capsule


{28 (estradiol 1 MG / norethindrone acetate 0.5 MG Oral Tablet) } Pack [Activella 1/0.5 28 Day]


acyclovir 200 MG in 5 mL Oral Suspension

acycycloguanosine 40 MG/ML Oral Suspension

acyclovir 200 MG per 5 ML Oral Suspension


aluminum hydroxide 1200 MG / milk of magnesia 1200 MG / dimethicone 120 MG per 30 ML Oral Suspension

aluminum hydroxide 200 MG / magnesium hydroxide 200 MG / simethicone 20 MG in 5 mL Oral Suspension

aluminum hydroxide 200 MG / milk of magnesia 200 MG / dimethicone 20 MG per 5 ML Oral Suspension

aluminum hydroxide 400 MG / milk of magnesia 400 MG / dimethicone 40 MG per 10 ML Oral Suspension

aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension


aluminum hydroxide 200 MG / magnesium hydroxide 200 MG / simethicone 25 MG Chewable Tablet

aluminum hydroxide 200 MG / milk of magnesia 200 MG / simethicone 25 MG Chewable Tab


albuterol 200 MCG/ACTUAT Inhalation Powder